INVE Technologies, Inc 10-Q for FY2021 Q1
INVE Technologies, Inc. (INVE)
About this 10-Q
INVE Technologies, Inc filed this 10-Q on May 11, 2021, covering the quarter ended March 31, 2021 (FY2021 Q1).
Headline figures
Quarter ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $22.16M
- up 22.3% from $18.12M a year earlier
- Net loss
- $1.47M
- compared with a net loss of $2.05M a year earlier
- Diluted EPS
- -$0.09
- compared with -$0.13 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
|
☑ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2021
OR
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ______ to ______
Commission File Number: 000-29440
IDENTIV, INC.
(Exact Name of Registrant as Specified in its Charter)
|
DELAWARE |
77-0444317 |
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
|
|
2201 Walnut Avenue, Suite 100 Fremont, California |
94538 |
|
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (949) 250-8888
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
|
Trading Symbol(s) |
|
Name of exchange on which registered |
|
|
Common Stock, $0.001 par value per share |
|
INVE |
|
The Nasdaq Stock Market LLC |
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer |
☐ |
|
Accelerated filer |
☐ |
|
Non-accelerated filer |
☑ |
|
Smaller reporting company |
☑ |
|
Emerging growth company |
☐ |
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
As of May 3, 2021, the registrant had 21,983,394 shares of common stock outstanding.
TABLE OF CONTENTS
|
|
|
|
Page |
|
|
|||
|
Item 1. |
|
3 |
|
|
|
|
Condensed Consolidated Balance Sheets as of March 31, 2021 and December 31, 2020 |
3 |
|
|
|
4 |
|
|
|
|
5 |
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2021 and 2020 |
6 |
|
|
|
Notes to Unaudited Condensed Consolidated Financial Statements |
7 |
|
Item 2. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
24 |
|
Item 3. |
|
33 |
|
|
Item 4. |
|
33 |
|
|
|
|
||
|
|
|||
|
Item 1. |
|
34 |
|
|
Item 1A. |
|
34 |
|
|
Item 2. |
|
34 |
|
|
Item 6. |
|
35 |
|
|
|
|
|
|
|
36 |
|||
2
IDENTIV, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, in thousands, except par value)
|
|
|
March 31, |
|
|
December 31, |
|
||
|
|
|
2021 |
|
|
2020 |
|
||
|
ASSETS |
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
11,518 |
|
|
$ |
11,409 |
|
|
Accounts receivable, net of allowances of $132 and $178 as of March 31, 2021 and December 31, 2020, respectively |
|
|
18,911 |
|
|
|
18,927 |
|
|
Inventories |
|
|
19,308 |
|
|
|
20,296 |
|
|
Prepaid expenses and other current assets |
|
|
3,065 |
|
|
|
2,813 |
|
|
Total current assets |
|
|
52,802 |
|
|
|
53,445 |
|
|
Property and equipment, net |
|
|
3,768 |
|
|
|
2,827 |
|
|
Operating lease right-of-use assets |
|
|
2,974 |
|
|
|
3,405 |
|
|
Intangible assets, net |
|
|
7,299 |
|
|
|
7,563 |
|
|
Goodwill |
|
|
10,281 |
|
|
|
10,266 |
|
|
Other assets |
|
|
1,142 |
|
|
|
1,171 |
|
|
Total assets |
|
$ |
78,266 |
|
|
$ |
78,677 |
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
10,217 |
|
|
$ |
10,964 |
|
|
Current portion - contractual payment obligation |
|
|
788 |
|
|
|
1,040 |
|
|
Current portion - financial liabilities, net of debt issuance costs of $136 and $59 as of March 31, 2021 and December 31, 2020, respectively |
|
|
22,334 |
|
|
|
20,084 |
|
|
Operating lease liabilities |
|
|
1,243 |
|
|
|
1,279 |
|
|
Deferred revenue |
|
|
1,634 |
|
|
|
1,981 |
|
|
Accrued compensation and related benefits |
|
|
2,858 |
|
|
|
2,985 |
|
|
Other accrued expenses and liabilities |
|
|
3,643 |
|
|
|
3,240 |
|
|
Total current liabilities |
|
|
42,717 |
|
|
|
41,573 |
|
|
Long-term operating lease liabilities |
|
|
1,875 |
|
|
|
2,272 |
|
|
Long-term deferred revenue |
|
|
331 |
|
|
|
385 |
|
|
Other long-term liabilities |
|
|
363 |
|
|
|
258 |
|
|
Total liabilities |
|
|
45,286 |
|
|
|
44,488 |
|
|
Commitments and contingencies (see Note 16) |
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
|
Series B convertible preferred stock, $0.001 par value: 5,000 shares authorized; 5,000 shares issued and outstanding as of March 31, 2021 and December 31, 2020 |
|
|
5 |
|
|
|
5 |
|
|
Common stock, $0.001 par value: 50,000 shares authorized; 19,581 and 19,450 shares issued and 18,161 and 18,055 shares outstanding as of March 31, 2021 and December 31, 2020, respectively |
|
|
19 |
|
|
|
19 |
|
|
Additional paid-in capital |
|
|
452,921 |
|
|
|
452,129 |
|
|
Treasury stock, 1,420 and 1,395 shares as of March 31, 2021 and December 31, 2020, respectively |
|
|
(10,186 |
) |
|
|
(9,933 |
) |
|
Accumulated deficit |
|
|
(412,074 |
) |
|
|
(410,609 |
) |
|
Accumulated other comprehensive income |
|
|
2,295 |
|
|
|
2,578 |
|
|
Total stockholders' equity |
|
|
32,980 |
|
|
|
34,189 |
|
|
Total liabilities and stockholders' equity |
|
$ |
78,266 |
|
|
$ |
78,677 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
IDENTIV, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Unaudited, in thousands, except per share data)
|
|
|
Three Months Ended March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Net revenue |
|
$ |
22,162 |
|
|
$ |
18,120 |
|
|
Cost of revenue |
|
|
14,470 |
|
|
|
10,620 |
|
|
Gross profit |
|
|
7,692 |
|
|
|
7,500 |
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
Research and development |
|
|
2,337 |
|
|
|
2,596 |
|
|
Selling and marketing |
|
|
4,064 |
|
|
|
4,497 |
|
|
General and administrative |
|
|
2,125 |
|
|
|
2,191 |
|
|
Restructuring and severance |
|
|
388 |
|
|
|
65 |
|
|
Total operating expenses |
|
|
8,914 |
|
|
|
9,349 |
|
|
Loss from operations |
|
|
(1,222 |
) |
|
|
(1,849 |
) |
|
Non-operating income (expense): |
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
(245 |
) |
|
|
(252 |
) |
|
Foreign currency gains (losses), net |
|
|
46 |
|
|
|
86 |
|
|
Loss before income tax provision |
|
|
(1,421 |
) |
|
|
(2,015 |
) |
|
Income tax provision |
|
|
(44 |
) |
|
|
(32 |
) |
|
Net loss |
|
|
(1,465 |
) |
|
|
(2,047 |
) |
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss: |
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
|
|
(283 |
) |
|
|
(480 |
) |
|
Comprehensive loss |
|
$ |
(1,748 |
) |
|
$ |
(2,527 |
) |
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share: |
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
(0.09 |
) |
|
$ |
(0.13 |
) |
|
Diluted |
|
$ |
(0.09 |
) |
|
$ |
(0.13 |
) |
|
Weighted average common shares outstanding, basic and diluted |
|
|
18,443 |
|
|
|
17,521 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
IDENTIV, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited, in thousands)
|
|
|
Series B Convertible Preferred Stock |
|
|
Common Stock |
|
|
Additional Paid-in |
|
|
Treasury |
|
|
Accumulated |
|
|
Accumulated Other Comprehensive |
|
|
Total Stockholders' |
|
|||||||||||||||
|
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Stock |
|
|
Deficit |
|
|
Income |
|
|
Equity |
|
|||||||||
|
Balances, December 31, 2019 |
|
|
5,000 |
|
|
$ |
5 |
|
|
|
16,986 |
|
|
$ |
18 |
|
|
$ |
447,965 |
|
|
$ |
(9,043 |
) |
|
$ |
(405,504 |
) |
|
$ |
2,025 |
|
|
$ |
35,466 |
|
|
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2,047 |
) |
|
|
— |
|
|
|
(2,047 |
) |
|
Unrealized loss from foreign currency translation adjustments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(480 |
) |
|
|
(480 |
) |
|
Issuance of common stock in connection with vesting of stock awards |
|
|
— |
|
|
|
— |
|
|
|
150 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
640 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
640 |
|
|
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units |
|
|
— |
|
|
|
— |
|
|
|
(48 |
) |
|
|
— |
|
|
|
— |
|
|
|
(225 |
) |
|
|
— |
|
|
|
— |
|
|
|
(225 |
) |
|
Issuance of common stock in connection with warrant exercise |
|
|
— |
|
|
|
— |
|
|
|
387 |
|
|
|
1 |
|
|
|
(1 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Balances, March 31, 2020 |
|
|
5,000 |
|
|
$ |
5 |
|
|
|
17,475 |
|
|
$ |
19 |
|
|
$ |
448,604 |
|
|
$ |
(9,268 |
) |
|
$ |
(407,551 |
) |
|
$ |
1,545 |
|
|
$ |
33,354 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series B Convertible Preferred Stock |
|
|
Common Stock |
|
|
Additional Paid-in |
|
|
Treasury |
|
|
Accumulated |
|
|
Accumulated Other Comprehensive |
|
|
Total Stockholders' |
|
|||||||||||||||
|
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Stock |
|
|
Deficit |
|
|
Income |
|
|
Equity |
|
|||||||||
|
Balances, December 31, 2020 |
|
|
5,000 |
|
|
$ |
5 |
|
|
|
18,055 |
|
|
$ |
19 |
|
|
$ |
452,129 |
|
|
$ |
(9,933 |
) |
|
$ |
(410,609 |
) |
|
$ |
2,578 |
|
|
$ |
34,189 |
|
|
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,465 |
) |
|
|
— |
|
|
|
(1,465 |
) |
|
Unrealized loss from foreign currency translation adjustments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(283 |
) |
|
|
(283 |
) |
|
Issuance of common stock in connection with vesting of stock awards |
|
|
— |
|
|
|
— |
|
|
|
98 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Proceeds of exercise of stock options |
|
|
— |
|
|
|
— |
|
|
|
5 |
|
|
|
— |
|
|
|
34 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
34 |
|
|
Stock-based compensation |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
758 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
758 |
|
|
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units |
|
|
— |
|
|
|
— |
|
|
|
(25 |
) |
|
|
— |
|
|
|
— |
|
|
|
(253 |
) |
|
|
— |
|
|
|
— |
|
|
|
(253 |
) |
|
Issuance of common stock in connection with warrant exercise |
|
|
— |
|
|
|
— |
|
|
|
28 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Balances, March 31, 2021 |
|
|
5,000 |
|
|
$ |
5 |
|
|
|
18,161 |
|
|
$ |
19 |
|
|
$ |
452,921 |
|
|
$ |
(10,186 |
) |
|
$ |
(412,074 |
) |
|
$ |
2,295 |
|
|
$ |
32,980 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
IDENTIV, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
|
|
|
Three Months Ended March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(1,465 |
) |
|
$ |
(2,047 |
) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
466 |
|
|
|
847 |
|
|
Accretion of interest on contractual payment obligation |
|
|
19 |
|
|
|
32 |
|
|
Amortization of debt issuance costs |
|
|
68 |
|
|
|
24 |
|
|
Stock-based compensation expense |
|
|
758 |
|
|
|
640 |
|
|
Impairment of right-of-use operating lease asset |
|
|
281 |
|
|
|
— |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
20 |
|
|
|
(1,671 |
) |
|
Inventories |
|
|
977 |
|
|
|
208 |
|
|
Prepaid expenses and other assets |
|
|
(223 |
) |
|
|
(170 |
) |
|
Accounts payable |
|
|
(736 |
) |
|
|
(324 |
) |
|
Contractual payment obligation liability |
|
|
(271 |
) |
|
|
(319 |
) |
|
Deferred revenue |
|
|
(401 |
) |
|
|
(547 |
) |
|
Accrued expenses and other liabilities |
|
|
96 |
|
|
|
(382 |
) |
|
Net cash used in operating activities |
|
|
(411 |
) |
|
|
(3,709 |
) |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(1,131 |
) |
|
|
(137 |
) |
|
Net cash used in investing activities |
|
|
(1,131 |
) |
|
|
(137 |
) |
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
Borrowings under revolving loan facility, net of issuance costs |
|
|
3,975 |
|
|
|
4,346 |
|
|
Repayments under revolving loan facility |
|
|
(1,793 |
) |
|
|
(209 |
) |
|
Repayments under East West Bank term loan |
|
|
— |
|
|
|
(500 |
) |
|
Taxes paid related to net share settlement of restricted stock units |
|
|
(253 |
) |
|
|
(225 |
) |
|
Proceeds from exercise of stock options |
|
|
34 |
|
|
|
— |
|
|
Net cash provided by financing activities |
|
|
1,963 |
|
|
|
3,412 |
|
|
Effect of exchange rates on cash and cash equivalents |
|
|
(312 |
) |
|
|
(253 |
) |
|
Net increase (decrease) in cash and cash equivalents |
|
|
109 |
|
|
|
(687 |
) |
|
Cash and cash equivalents at beginning of period |
|
|
11,409 |
|
|
|
9,383 |
|
|
Cash and cash equivalents at end of period |
|
$ |
11,518 |
|
|
$ |
8,696 |
|
|
Supplemental Disclosures of Cash Flow Information: |
|
|
|
|
|
|
|
|
|
Interest paid |
|
$ |
170 |
|
|
$ |
228 |
|
|
Taxes paid, net |
|
$ |
15 |
|
|
$ |
39 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
6
IDENTIV, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2021
1. Basis of Presentation
The accompanying unaudited condensed consolidated financial statements include the accounts of Identiv, Inc. and its wholly owned subsidiaries (the “Company”). All intercompany balances and transactions have been eliminated in consolidation.
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements have been included. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021 or any future period. The unaudited condensed consolidated balance sheet as of December 31, 2020 has been derived from audited consolidated financial statements at that date, but does not include all disclosures required by U.S. GAAP for complete financial statements. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Risk Factors,” and the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.
2. Significant Accounting Policies and Recent Accounting Pronouncements
Significant Accounting Policies
No material changes have been made to the Company's significant accounting policies disclosed in Note 2, Significant Accounting Policies and Recent Accounting Pronouncements, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.
Recent Accounting Pronouncements
In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which requires measurement and recognition of expected credit losses for financial assets held at the reporting date based on external information, or a combination of both relating to past events, current conditions, and reasonable and supportable forecasts. ASU 2016-13 replaces the existing incurred loss impairment model with a forward-looking expected credit loss model which will result in earlier recognition of credit losses. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19, Codification Improvement to Topic 326, Financial Instruments – Credit Losses, ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, ASU 2019-05, Financial Instruments Credit Losses (Topic 326) Targeted Transition Relief, ASU 2016-13, the FASB issued ASU 2019-10 Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842), and ASU 2019-11 Codification Improvements to Topic 326, Financial Instruments-Credit Losses. The subsequent ASUs do not change the core principle of the guidance in ASU 2016-13. Instead, these amendments are intended to clarify and improve operability of certain topics included within ASU 2016-13.
Additionally, ASU No. 2019-10 defers the effective date for the adoption of the new standard on credit losses for public filers that are considered small reporting companies as defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, which will be fiscal 2023 for the Company if it continues to be classified as a smaller reporting company. In February 2020, the FASB issued ASU 2020-02, which provides guidance regarding methodologies, documentation, and internal controls related to expected credit losses. The subsequent amendments will have the same effective date and transition requirements as ASU No. 2016-13. Early adoption is permitted. Topic 326 requires a modified retrospective approach by recording a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. While the Company is currently evaluating the impact of Topic 326, the Company does not expect the adoption of the ASU to have a material impact on its consolidated financial statements.
In December 2019, FASB issued ASU 2019-12, Income Taxes (740), Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which simplifies the accounting for incomes taxes by removing certain exceptions to the general principles in Topic 740 and amending existing guidance to improve consistent application. ASU 2019-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020, with early adoption permitted. This standard did not have a material impact on the Company’s condensed consolidated financial statements.
7
3. Revenue
Revenue Recognition
Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters into contracts that can include various combinations of its products, software licenses, and services, which are generally capable of being distinct and accounted for as separate performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation, generally on a relative basis using its standalone selling price. The stated contract value is generally the transaction price to be allocated to the separate performance obligations. Revenue is recognized net of any taxes collected from customers that are subsequently remitted to governmental authorities.
Nature of Products and Services
The Company derives revenues from sales of hardware products, software licenses, subscriptions, professional services, software maintenance and support, and extended hardware warranties.
Hardware Product Revenue — The Company generally has two performance obligations in arrangements involving the sale of hardware products. The first performance obligation is to transfer the hardware product (which includes software integral to the functionality of the hardware product). The second performance obligation is to provide assurance that the product complies with its agreed-upon specifications and is free from defects in material and workmanship for a period of one to three years (i.e., assurance warranty). The entire transaction price is allocated to the hardware product and is generally recognized as revenue at the time of delivery because the customer obtains control of the product at that point in time. The Company has concluded that control generally transfers at that point in time because the customer has title to the hardware, physical possession, and a present obligation to pay for the hardware. None of the transaction price is allocated to the assurance warranty component, as the Company accounts for these product warranty costs in accordance with Accounting Standards Codification ("ASC”) 460, Guarantees (“ASC 460”).
Software License Revenue — The Company’s license arrangements grant customers the perpetual right to access and use the licensed software products at the outset of an arrangement. Technical support and software updates are generally made available throughout the term of the support agreement, which is generally one to three years. The Company accounts for these arrangements as two performance obligations: (1) the software licenses, and (2) the related updates and technical support. The software license revenue is recognized upon delivery of the license to the customer, while the software updates and technical support revenue is recognized over the term of the support contract.
Subscription Revenue — Subscription revenue consist of fees received in consideration for providing customers access to one or more of the Company’s software-as-a-service (“SaaS”) based solutions. These SaaS arrangements include access to the Company’s licensed software and, in certain arrangements, use of various hardware devices over the contract term. These SaaS arrangements do not provide the customer the right to take possession of the software supporting the subscription service, or if applicable, any hardware devices at any time during the contract period, and as such are not considered separate performance obligations. Revenue is recognized ratably on a straight-line basis over the term of the contract beginning when the service is made available to the customer. Subscription contract terms range from month-to-month to six years in length and billed monthly or annually.
Professional Services Revenue — Professional services revenue consists primarily of programming customization services performed relating to the integration of the Company’s software products with the customers other systems, such as human resources systems. Professional services contracts are generally billed on a time and materials basis and revenue is recognized as the services are performed.
Software Maintenance and Support Revenue — Support and maintenance contract revenue consists of the services provided to support the specialized programming applications performed by the Company’s professional services group. Support and maintenance contracts are typically billed at inception of the contract and recognized as revenue over the contract period, typically over a one or three year period.
Extended Hardware Warranties Revenue — Sales of the Company’s hardware products may also include optional extended hardware warranties, which typically provide assurance that the product will continue function as initially intended. Extended hardware warranty contracts are typically billed at inception of the contract and recognized as revenue over the respective contract period, typically over one to two year periods after the expiration of the original assurance warranty.
8
|
Performance Obligation |
|
When Performance Obligation is Typically Satisfied |
|
When Payment is Typically Due |
|
How Standalone Selling Price is Typically Estimated |
|
Hardware products |
|
When customer obtains control of the product (point-in-time) |
|
Within 30-60 days of shipment |
|
Observable in transactions without multiple performance obligations |
|
Software licenses |
|
When license is delivered to customer or made available for download, and the applicable license period has begun (point-in-time) |
|
Within 30-60 days of the beginning of license period |
|
Established pricing practices for software licenses bundled with software maintenance, which are separately observable in renewal transactions |
|
Subscriptions |
|
Ratably over the course of the subscription term (over time) |
|
In advance of subscription term |
|
Contractually stated or list price |
|
Professional services |
|
As services are performed and/or when contract is fulfilled (point-in-time) |
|
Within 30-60 days of delivery |
|
Observable in transactions without multiple performance obligations |
|
Software maintenance and support services |
|
Ratably over the course of the support contract (over time) |
|
Within 30-60 days of the beginning of the contract period |
|
Observable in renewal transactions |
|
Extended hardware warranties |
|
Ratably over the course of the support contract (over time) |
|
Within 30-60 days of the beginning of the contract period |
|
Observable in renewal transactions |
Significant Judgments
The Company’s contracts with customers often include promises to transfer multiple products and services to a customer. For such arrangements, the Company allocates the transaction price to each performance obligation based on its relative standalone selling price (“SSP”).
Judgment is required to determine the SSP for each distinct performance obligation in a contract. For the majority of items, the Company estimates SSP using historical transaction data. The Company uses a range of amounts to estimate SSP when it sells each of the products and services separately and needs to determine whether there is a discount to be allocated based on the relative SSP of the various products and services. In instances where SSP is not directly observable, such as when the product or service is not sold separately, the Company determines the SSP using information that may include market conditions and other observable inputs. The determination of SSP is an ongoing process and information is reviewed regularly in order to ensure SSPs reflect current information or trends.
Disaggregation of Revenue
The Company disaggregates revenue from contracts with customers based on the timing of transfer of goods or services to customers (point-in-time or over time) and geographic region based on the shipping location of the customer. The geographic regions that are tracked are the Americas, Europe and the Middle East, and Asia-Pacific regions.
Total net revenue based on the disaggregation criteria described above is as follows (in thousands):
|
|
Three Months Ended March 31, |
|
|||||||||||||||||||||
|
|
2021 |
|
|
2020 |
|
||||||||||||||||||
|
|
Point-in- Time |
|
|
Over Time |
|
|
Total |
|
|
Point-in- Time |
|
|
Over Time |
|
|
Total |
|
||||||
|
Americas |
$ |
14,396 |
|
|
$ |
752 |
|
|
$ |
15,148 |
|
|
$ |
12,705 |
|
|
$ |
1,163 |
|
|
$ |
13,868 |
|
|
Europe and the Middle East |
|
2,364 |
|
|
|
96 |
|
|
|
2,460 |
|
|
|
2,504 |
|
|
|
97 |
|
|
|
2,601 |
|
|
Asia-Pacific |
|
4,554 |
|
|
|
— |
|
|
|
4,554 |
|
|
|
1,651 |
|
|
|
— |
|
|
|
1,651 |
|
|
Total |
$ |
21,314 |
|
|
$ |
848 |
|
|
$ |
22,162 |
|
|
$ |
16,860 |
|
|
$ |
1,260 |
|
|
$ |
18,120 |
|
9
Contract Balances
Amounts invoiced in advance of services being provided are accounted for as deferred revenue. Nearly all of the Company’s deferred revenue balance is related to software maintenance contracts. Payment terms and conditions vary by contract type, although payment is typically due within 30 to 90 days of contract inception. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts do not include a significant financing component. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing the Company’s products and services, not to receive financing from its customers.
Changes in deferred revenue during the three months ended March 31, 2021 and March 2020 were as follows (in thousands):
|
|
|
Three Months Ended March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Deferred revenue, beginning of period |
|
$ |
2,366 |
|
|
$ |
2,833 |
|
|
Deferral of revenue billed in current period, net of recognition |
|
|
392 |
|
|
|
384 |
|
|
Recognition of revenue deferred in prior periods |
|
|
(793 |
) |
|
|
(931 |
) |
|
Deferred revenue as, end of period |
|
$ |
1,965 |
|
|
$ |
2,286 |
|
Unsatisfied Performance Obligations
Revenue expected to be recognized in future periods related to remaining performance obligations, excluding revenue pertaining to contracts that have an original expected duration of one year or less, and contracts where revenue is recognized as invoiced, was approximately $0.8 million as of March 31, 2021. Since the Company typically invoices customers at contract inception, this amount is included in the deferred revenue balance. As of March 31, 2021, the Company expects to recognize 53% of the revenue related to these unsatisfied performance obligations during the remainder of 2021, 32% during 2022, and 15% thereafter.
Assets Recognized from the Costs to Obtain a Contract with a Customer
The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if it expects the benefit of those costs to be longer than one year. The Company has determined that certain sales incentive programs (i.e., commissions) meet the requirements to be capitalized. Capitalized incremental costs related to contracts are amortized over the respective contract periods. For the three months ended March 31, 2021, total capitalized costs to obtain contracts were immaterial.
4. Fair Value Measurements
The Company determines the fair values of its financial instruments based on a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. Under ASC 820, Fair Value Measurement and Disclosures (“ASC 820”), the fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value:
|
|
● |
Level 1 – Quoted prices (unadjusted) for identical assets and liabilities in active markets; |
|
|
● |
Level 2 – Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly; and |
|
|
● |
Level 3 – Unobservable inputs. |
Assets and Liabilities Measured at Fair Value on a Recurring Basis
As of March 31, 2021 and December 31, 2020, the only assets measured and recognized at fair value on a recurring basis were nominal cash equivalents. As of March 31, 2021 and December 31, 2020, there were no liabilities measured and recognized at fair value on a recurring basis, other than contingent consideration related to prior acquisitions as of December 31, 2020 which had no fair value.
10
Assets and Liabilities Measured at Fair Value on a Non-recurring Basis
Certain of the Company's assets, including goodwill, intangible assets, and privately-held investments, are measured at fair value on a nonrecurring basis if impairment is indicated. Purchased intangible assets are measured at fair value primarily using discounted cash flow projections. For additional discussion of measurement criteria used in evaluating potential impairment involving goodwill and intangible assets, refer to Note 5, Goodwill and Intangible Assets.
As of March 31, 2021 and December 31, 2020, the Company had $348,000 of privately-held investments measured at fair value on a nonrecurring basis, which were classified as Level 3 assets due to the absence of quoted market prices and inherent lack of liquidity. The Company reviews its investments to identify and evaluate investments that have an indication of possible impairment. The Company adjusts the carrying value for its privately-held investments for any impairment if the fair value is less than the carrying value of the respective assets on an other-than-temporary basis. The amount of privately-held investments is included in other assets in the accompanying condensed consolidated balance sheets.
As of March 31, 2021 and December 31, 2020, there were no liabilities that are measured and recognized at fair value on a non-recurring basis.
Assets and Liabilities Not Measured at Fair Value
The carrying amounts of the Company's accounts receivable, prepaid expenses and other current assets, accounts payable, and other accrued liabilities approximate fair value due to their short maturities. The carrying value of the Company’s financial liabilities approximates fair value based upon borrowing rates currently available to the Company for loans with similar terms.
5. Goodwill and Intangible Assets
Goodwill
The following table summarizes the activity in goodwill (in thousands):
|
|
|
Identity |
|
|
Premises |
|
|
Total |
|
|||
|
Balance at December 31, 2020 |
|
$ |
3,554 |
|
|
$ |
6,712 |
|
|
$ |
10,266 |
|
|
Currency translation adjustment |
|
|
— |
|
|
|
15 |
|
|
|
15 |
|
|
Balance at March 31, 2021 |
|
$ |
3,554 |
|
|
$ |
6,727 |
|
|
$ |
10,281 |
|
In accordance with ASC 350, Intangibles – Goodwill and Other, the Company tests goodwill for impairment on an annual basis, in the fourth quarter, or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. The Company performs an initial assessment of qualitative factors to determine whether the existence of events and circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In performing the qualitative assessment, the Company identifies and considers the significance of relevant key factors, events, and circumstances that affect the fair value of its reporting units. These factors include external factors such as macroeconomic, industry, and market conditions, as well as entity-specific factors, such as actual and planned financial performance. If, after assessing the totality of relevant events and circumstances, the Company determines that it is more likely than not that the fair value of the reporting unit exceeds its carrying value and there is no indication of impairment, no further testing is performed; however, if the Company concludes otherwise, then the Company will perform the quantitative impairment test which compares the estimated fair value of the reporting unit to its carrying value, including goodwill. If the carrying amount of the reporting unit is in excess of its fair value, an impairment loss would be recorded in the consolidated statement of comprehensive loss. During the quarters ended March 31, 2021 and 2020, the Company noted no indicators of goodwill impairment and concluded no further testing was necessary.
11
Intangible Assets
The following table summarizes the gross carrying amount and accumulated amortization for intangible assets resulting from acquisitions (in thousands):
|
|
|
|
|
|
|
Developed |
|
|
Customer |
|
|
|
|
|
||
|
|
|
Trademarks |
|
|
Technology |
|
|
Relationships |
|
|
Total |
|
||||
|
Amortization period (in years) |
|
5 |
|
|
10 – 12 |
|
|
4 – 12 |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross carrying amount at March 31, 2021 |
|
$ |
767 |
|
|
$ |
9,132 |
|
|
$ |
15,775 |
|
|
$ |
25,674 |
|
|
Accumulated amortization |
|
|
(419 |
) |
|
|
(5,878 |
) |
|
|
(12,078 |
) |
|
|
(18,375 |
) |
|
Intangible assets, net at March 31, 2021 |
|
$ |
348 |
|
|
$ |
3,254 |
|
|
$ |
3,697 |
|
|
$ |
7,299 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross carrying amount at December 31, 2020 |
|
$ |
765 |
|
|
$ |
9,123 |
|
|
$ |
15,771 |
|
|
$ |
25,659 |
|
|
Accumulated amortization |
|
|
(382 |
) |
|
|
(5,773 |
) |
|
|
(11,941 |
) |
|
|
(18,096 |
) |
|
Intangible assets, net at December 31, 2020 |
|
$ |
383 |
|
|
$ |
3,350 |
|
|
$ |
3,830 |
|
|
$ |
7,563 |
|
Each period, the Company evaluates the estimated remaining useful lives of purchased intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization. If a revision to the remaining period of amortization is warranted, amortization is prospectively adjusted over the remaining useful life of the intangible asset. Intangible assets subject to amortization are amortized on a straight-line basis over their useful lives as indicated in the table above. The Company performs an evaluation of it its amortizable intangible assets for impairment at the end of each reporting period. The Company did not identify any impairment indicators during the three months ended March 31, 2021 and 2020.
The following table summarizes the amortization expense included in the condensed consolidated statements of comprehensive loss for the three months ended March 31, 2021 and 2020, respectively (in thousands):
|
|
|
Three Months Ended March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Cost of revenue |
|
$ |
119 |
|
|
$ |
224 |
|
|
Selling and marketing |
|
|
160 |
|
|
|
418 |
|
|
Total |
|
$ |
279 |
|
|
$ |
642 |
|
The estimated annual future amortization expense for purchased intangible assets with definite lives as of March 31, 2021 was as follows (in thousands):
|
2021 (remaining nine months) |
|
$ |
842 |
|
|
2022 |
|
|
1,122 |
|
|
2023 |
|
|
1,045 |
|
|
2024 |
|
|
969 |
|
|
2025 |
|
|
969 |
|
|
Thereafter |
|
|
2,352 |
|
|
Total |
|
$ |
7,299 |
|
12
6. Balance Sheet Components
The Company’s inventories are stated at the lower of cost or net realizable value. Inventories consists of (in thousands):
|
|
|
March 31, |
|
|
December 31, |
|
||
|
|
|
2021 |
|
|
2020 |
|
||
|
Raw materials |
|
$ |
6,119 |
|
|
$ |
6,518 |
|
|
Work-in-progress |
|
|
11 |
|
|
|
34 |
|
|
Finished goods |
|
|
13,178 |
|
|
|
13,744 |
|
|
Total |
|
$ |
19,308 |
|
|
$ |
20,296 |
|
Property and equipment, net consists of (in thousands):
|
|
|
March 31, |
|
|
December 31, |
|
||
|
|
|
2021 |
|
|
2020 |
|
||
|
Building and leasehold improvements |
|
$ |
1,450 |
|
|
$ |
1,498 |
|
|
Furniture, fixtures and office equipment |
|
|
1,311 |
|
|
|
1,295 |
|
|
Plant and machinery |
|
|
12,541 |
|
|
|
11,429 |
|
|
Purchased software |
|
|
2,189 |
|
|
|
2,191 |
|
|
Total |
|
|
17,491 |
|
|
|
16,413 |
|
|
Accumulated depreciation |
|
|
(13,723 |
) |
|
|
(13,586 |
) |
|
Property and equipment, net |
|
$ |
3,768 |
|
|
$ |
2,827 |
|
The Company recorded depreciation expense of $0.2 million during each of the three months ended March 31, 2021 and 2020.
Other accrued expenses and liabilities consist of (in thousands):
|
|
|
March 31, |
|
|
December 31, |
|
||
|
|
|
2021 |
|
|
2020 |
|
||
|
Accrued professional fees |
|
$ |
562 |
|
|
$ |
586 |
|
|
Customer deposits |
|
|
370 |
|
|
|
72 |
|
|
Accrued warranties |
|
|
335 |
|
|
|
321 |
|
|
Accrued restructuring |
|
|
759 |
|
|
|
801 |
|
|
Other accrued expenses |
|
|
1,617 |
|
|
|
1,460 |
|
|
Total |
|
$ |
3,643 |
|
|
$ |
3,240 |
|
7. Contractual Payment Obligation
Hirsch Electronics Corporation (“Hirsch”) Acquisition – Secure Keyboards and Secure Networks. Prior to the Company’s acquisition of Hirsch in 2009, in November 1994, Hirsch had entered into a settlement agreement (the “1994 Settlement Agreement”) with two limited partnerships, Secure Keyboards, Ltd. (“Secure Keyboards”) and Secure Networks, Ltd. (“Secure Networks”). On April 8, 2009, the 1994 Settlement Agreement was amended and restated to replace the royalty-based payment arrangement with an installment payment schedule with contractual payments to be made in future periods through 2021 (the “2009 Settlement Agreement”). On April 30, 2009, as part of the acquisition of Hirsch, the Company provided Secure Keyboards and Secure Networks with a limited guarantee of Hirsch’s payment obligation under the 2009 Settlement Agreement.
On April 13, 2020, the Company, Secure Keyboards, and Secure Networks, amended the 2009 Settlement Agreement. The amendment reduced the amount of quarterly payments due under the obligation in 2020, and requires three additional quarterly payments in 2021, increasing the total amount due under the obligation by approximately $90,000. The Company’s remaining payment obligation under the 2009 Settlement Agreement, as amended, was extended through October 31, 2021. The Company included approximately $19,000 and $32,000 of interest expense during the three months ended March 31, 2021 and 2020, respectively, in its condensed consolidated statements of comprehensive loss for interest accreted on the payment obligation.
13
The payment obligation under the 2009 Settlement Agreement, as amended, as of March 31, 2021, is as follows (in thousands):
|
2021 (remaining nine months) |
|
$ |
812 |
|
|
Present value discount factor |
|
|
(24 |
) |
|
Total |
|
$ |
788 |
|
8. Financial Liabilities
Financial liabilities consist of (in thousands):
|
|
|
March 31, |
|
|
December 31, |
|
||
|
|
|
2021 |
|
|
2020 |
|
||
|
Revolving loan facility |
|
$ |
16,755 |
|
|
$ |
14,428 |
|
|
April 21 Funds promissory notes |
|
|
2,800 |
|
|
|
2,800 |
|
|
Paycheck Protection Program promissory note |
|
|
2,915 |
|
|
|
2,915 |
|
|
Total |
|
|
22,470 |
|
|
|
20,143 |
|
|
Less: Current maturities of financial liabilities |
|
|
(22,334 |
) |
|
|
(20,084 |
) |
|
Less: Unamortized debt issuance costs |
|
|
(136 |
) |
|
|
(59 |
) |
|
Long-term financial liabilities |
|
$ |
— |
|
|
$ |
— |
|
East West Bank
On February 8, 2017, the Company entered into a Loan and Security Agreement with East West Bank (“EWB”). Following subsequent amendments, on February 8, 2021 the Company amended and restated the Loan and Security Agreement in its entirety (the “Loan and Security Agreement”). The Loan and Security Agreement provides for a $20.0 million revolving loan facility subject to a borrowing base and a $4.0 million non-formula revolving loan facility that is not subject to a borrowing base. The Company’s obligations under the Loan and Security Agreement are collateralized by substantially all of its assets.
The maturity date of the main revolving loan facility is February 8, 2023. The non-formula revolving loan facility will terminate on February 7, 2022, however the Company may, at its option if certain conditions are met, convert prior to their maturity any loans under the non-formula revolving loan facility to a term loan that will fully amortize and mature on February 1, 2025. Advances under the revolving loan facilities and the term loan (if converted) will initially bear interest at a per annum rate equal to the prime rate as determined under the Loan and Security Agreement plus 0.25%. On April 30, 2021, the Company entered into an amendment to its Loan and Security Agreement which reduced the per annum interest rate to the prime interest rate.
The Company may voluntarily prepay amounts outstanding under the revolving loan facilities and the term loan without prepayment charges. In the event the Loan and Security Agreement is terminated prior to February 8, 2023, the Company would be required to pay an early termination fee in the amount of 2.0% of the main revolving loan line if terminated prior to February 8, 2022 and 1% of the main revolving loan line thereafter. Additional borrowing requests under the revolving loan facilities are subject to various customary conditions precedent, including a borrowing base for the main revolving loan facility.
The Loan and Security Agreement contains customary representations and warranties and customary affirmative and negative covenants, including, limits or restrictions on the Company’s ability to incur liens, incur indebtedness, make certain restricted payments (including dividends), merge or consolidate and dispose of assets. In addition, the Loan and Security Agreement contains financial covenants requiring that the Company (i) hold $5 million in unrestricted cash in accounts with EWB, (ii) maintain a monthly minimum trailing six-month EBITDA of $0.6 million for the first two quarters of 2021 and $1.2 million thereafter and (iii) maintain, if the Company converts into the term loan and starting with the quarter ending March 31, 2022, a quarterly fixed charge coverage ratio of at least 1.35:1.00.
The Loan and Security Agreement contains customary events of default that entitle EWB to cause any or all of the Company’s indebtedness under it to become immediately due and payable. The events of default (some of which are subject to applicable grace or cure periods), include, among other things, non-payment defaults, covenant defaults, cross-defaults to other material indebtedness, bankruptcy and insolvency defaults and material judgment defaults. Upon the occurrence and during the continuance of an event of default, EWB may terminate its lending commitment and/or declare all or any part of the unpaid principal of all loans, all interest accrued and unpaid thereon and all other amounts payable under the Loan and Security Agreement to be immediately due and payable.
As of March 31, 2021, the Company was in compliance with all financial covenants under the Revolving Loan Facility.
14
April 21 Funds
On May 5, 2020, the Company issued secured subordinated promissory notes in an aggregate principal amount of $4.0 million (the “Notes”) to 21 April Fund, LP and 21 April Fund, Ltd. (collectively referred to as the “April 21 Funds”) pursuant to a Note and Warrant Purchase Agreement entered into with the April 21 Funds (the “Note Purchase Agreement”). The Notes are collateralized by the Company’s assets, but subordinate to the Company’s obligations to EWB under its Loan and Security Agreement. Proceeds from the sale of the Notes were only to be used for expenses incurred by the Company in connection with its provisions of goods and services under a statement of work with a third party. The Notes have an initial term of nine months and do not bear interest during this period. If the Notes are not repaid on or before the nine-month anniversary of issuance, (a) the Notes will thereafter bear interest of 8% per annum, payable quarterly, and (b) additional warrants to purchase common stock would be issuable to the April 21 Funds for each month all or a portion of the Notes remain unpaid, as further detailed in the Note Purchase Agreement. In the event the Notes are not paid in full by the first anniversary of their issuance, May 5, 2021, they shall thereafter bear interest of 12% per annum, payable quarterly, and additional warrants would be issuable to the April 21 Funds.
As discussed in Note 10, Stockholders’ Equity, the fair value of the warrants issued to April 21 Funds was calculated using the Black Scholes pricing model using the following assumptions: estimated volatility of 63.2%, risk free interest rate of 0.24%, no dividend yield, and an expected life of three years. The relative fair value of the warrants of $290,000 was recorded as a direct reduction from the carrying amount of the Notes and was being amortized as interest expense over the term of the April 21 Funds promissory notes.
On February 5, 2021, the Company entered into an amendment to the secured subordinated promissory note with April 21 Funds, which extended the initial term of the Notes to March 31, 2021. As a result of the amendment, if the Notes were repaid on or before March 31, 2021, the Company would incur no further interest on the Notes, or be obligated to issue additional warrants. As of March 31, 2021, the principal amount outstanding under the Notes was $2.8 million.
On March 31, 2021, April 21 Funds waived any additional warrants issuable, and interest payable, to April 21 Funds through May 5, 2021. On April 13, 2021, the Company repaid the remaining principal amount outstanding of $2.8 million.
Paycheck Protection Program
On April 9, 2020, the Company entered into a promissory note (the “PPP Note”) under the Paycheck Protection Program established under Section 1102 of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act. The PPP Note is dated April 8, 2020 with EWB. The Company borrowed a principal amount of approximately $2.9 million. The interest on the PPP Note is 1.0% per annum. The PPP Note is payable two years from the date of the PPP Note, and there is no prepayment penalty. All interest which accrues during the initial six months of the loan period is deferred and payable on the maturity date of the PPP Note. Notes issued under the CARES Act may be eligible for forgiveness in whole or in part in accordance with Small Business Administration rules established for the Paycheck Protection Program. The principal amount outstanding, including accrued interest, is included in current portion – financial liabilities and other accrued expenses and liabilities in the accompanying condensed consolidated balance sheets, as the Company expects all amounts outstanding will be forgiven in 2021.
9. Income Taxes
The Company conducts business globally and, as a result, files federal, state and foreign tax returns. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for amounts it believes are the probable outcomes, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the condensed consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal.
The Company applies the provisions of, and accounted for uncertain tax positions in accordance with ASC 740, Income Taxes (“ASC 740”), which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. It prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.
The Company generally is no longer subject to tax examinations for years prior to 2016. However, if loss carryforwards of tax years prior to 2016 are utilized in the U.S., these tax years may become subject to investigation by the tax authorities. While timing of the resolution and/or finalization of tax audits is uncertain, the Company does not believe that its unrecognized tax benefits would materially change in the next 12 months.
15
On March 11, 2021, President Biden signed the American Rescue Plan Act of 2021 (the “Act”) into law. The $1.9 trillion Act includes COVID-19 relief, as well as broader stimulus, but also includes several revenue-raising and business tax provisions. The CARES Act also includes several significant provisions for corporations, including the usage of net operating losses and payroll benefits. Several foreign (non-U.S.) jurisdictions in which we operate have taken similar economic stimulus measures. The Act and the CARES Act had no material impact on the Company’s condensed consolidated financial statements and disclosures.
10. Stockholders’ Equity
Series B Convertible Preferred Stock Dividend Accretion
The following tables summarize Series B convertible preferred stock and the accretion of dividend activity for the three months ended March 31, 2021 and 2020 (in thousands):
|
|
|
March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Series B Convertible Preferred Stock: |
|
|
|
|
|
|
|
|
|
Balance at beginning of period |
|
$ |
22,969 |
|
|
$ |
21,875 |
|
|
Cumulative dividends on Series B convertible preferred stock |
|
|
284 |
|
|
|
270 |
|
|
Balance at end of period |
|
$ |
23,253 |
|
|
$ |
22,145 |
|
|
Number of Common Shares Issuable Upon Conversion: |
|
|
|
|
|
|
|
|
|
Number of shares at beginning of period |
|
|
5,742 |
|
|
|
5,469 |
|
|
Cumulative dividends on Series B convertible preferred stock |
|
|
71 |
|
|
|
67 |
|
|
Number of shares at end of period |
|
|
5,813 |
|
|
|
5,536 |
|
Based on the current conversion price, the outstanding shares, including the accretion of dividends, of Series B convertible preferred stock as of March 31, 2021 would be convertible into 5,813,161 shares of the Company’s common stock. However, the conversion rate will be subject to adjustment in certain instances, such as if the Company issues shares of its common stock at a price less than $4.00 per common share, subject to a minimum conversion price of $3.27 per share. As of March 31, 2021, none of the contingent conditions to adjust the total common shares to convert the shares had been met.
Each share of Series B convertible preferred stock is entitled to a cumulative annual dividend of 5% for the first six (6) years following the issuance of such share and 3% for each year thereafter, with the Company retaining the option to settle each year’s dividend after the tenth (10th) year in cash. The dividends accrue and are payable in kind upon such time as the shares convert into the Company’s common stock. In general, the shares are not entitled to vote except in certain limited cases, including in change of control transactions where the expected price per share distributable to the Company’s stockholders is expected to be less than $4.00 per share. The Certificate of Designation with respect to the Series B convertible preferred stock further provides that in the event of, among other things, any change of control, liquidation or dissolution of the Company, the holders of the Series B convertible preferred stock will be entitled to receive, on a pari passu basis with the holders of the common stock, the same amount and form of consideration that the holders of the Company’s common stock receive (on an as-if-converted-to-common-stock basis and without regard to the Ownership Limitation applicable to the Series B convertible preferred stock).
Common Stock Warrants
On February 8, 2017, the Company entered into a Loan and Security Agreement with EWB. In connection with the Loan and Security Agreement, the Company issued to EWB a warrant (the "EWB Warrant") to purchase up to 40,000 shares of the Company's common stock at a per share exercise price of $3.64 which were immediately exercisable for cash or by net exercise and expired on February 8, 2022. On May 5, 2020, the Company entered into an amendment to the Loan and Security Agreement, which included amending the EWB Warrant, reducing its exercise price from $3.64 to $3.50 per share and extended the expiration date of the EWB Warrant from February 8, 2022 to February 8, 2023. The Company calculated the fair value of the amended EWB Warrant using the Black Scholes pricing model using the following assumptions: estimated volatility of 63.2%, risk free interest rate of 0.24%, no dividend yield, and an expected life of three years. The fair value of the amended EWB Warrant of $42,000, as well as legal and administrative costs of $92,000, were recorded as a direct reduction from the carrying amount of the Revolving Loan Facility and amortized as interest expense over the remaining term of the Loan and Security Agreement. On February 11, 2021, EWB exercised their warrant on a cashless net exercise basis receiving 27,599 shares of the Company’s common stock.
16
On May 5, 2020, the Company entered into a Note and Warrant Purchase Agreement with the April 21 Funds, as discussed in Note 8, Financial Liabilities, in which the Company issued warrants (“April 21 Funds Warrants”) to purchase 275,000 shares of common stock of the Company. The April 21 Funds Warrants have a term of three years (subject to early termination upon the closing of an acquisition); provided, that in the event that the Note is not paid in full by the nine-month anniversary of issuance, the term of the April 21 Funds Warrants shall be extended for a period of time equal to the period of time from such nine-month anniversary until the date the Note is fully paid (“Extension Warrants”). The Extension Warrants would have a term of three years from the date of issuance of the latest Extension Warrant to be issued (subject to early termination upon an acquisition). The shares of common stock issuable upon exercise of the April 21 Fund Warrants and any Extension Warrants that may be issued are entitled to the same resale registration rights granted to the April 21 Funds Warrants under the Stockholders Agreement dated December 21, 2017 in connection with the April 21 Funds previous purchase of certain securities of the Company.
Below is the summary of outstanding warrants issued by the Company as of March 31, 2021:
|
Warrant Type |
|
Number of Shares Issuable Upon Exercise |
|
|
Weighted Average Exercise Price |
|
|
Issue Date |
|
Expiration Date |
||
|
April 21 Funds Warrants |
|
|
275,000 |
|
|
$ |
3.50 |
|
|
May 5, 2020 |
|
May 5, 2023 |
Common Stock Reserved for Future Issuance
Common stock reserved for future issuance as of March 31, 2021 was as follows:
|
Exercise of outstanding stock options, vesting of restricted stock units ("RSU"), vesting of performance stock units ("PSU"), and issuance of RSUs vested but not released |
|
|
1,703,042 |
|
|
Employee Stock Purchase Plan |
|
|
293,888 |
|
|
Shares of common stock available for grant under the 2011 Plan |
|
|
1,005,950 |
|
|
Warrants to purchase common stock |
|
|
275,000 |
|
|
Shares of common stock issuable upon conversion of Series B convertible preferred stock |
|
|
7,541,449 |
|
|
Total |
|
|
10,819,329 |
|
11. Stock-Based Compensation
Stock Incentive Plans
The Company maintains a stock-based compensation plan, the 2011 Incentive Compensation Plan, as amended, (the “2011 Plan”), to attract, motivate, retain and reward employees, directors and consultants by providing its Board or a committee of the Board the discretion to award equity incentives to these persons.
On June 6, 2011, the Company’s stockholders approved the 2011 Plan, which is administered by the Compensation Committee of the Board. The 2011 Plan provides that stock options, stock units, restricted shares, and stock appreciation rights may be granted to executive officers, directors, consultants, and other key employees. The Company reserved 400,000 shares of common stock under the 2011 Plan, plus 459,956 shares of common stock that remained available for delivery under the 2007 Plan and the 2010 Plan as of June 6, 2011. In aggregate, as of June 6, 2011, 859,956 shares were available for future grant under the 2011 Plan, including shares rolled over from the 2007 Plan and the 2010 Plan. Subsequent to June 6, 2011 through March 31, 2021, the number of shares of common stock authorized for issuance under the 2011 Plan has been increased by an aggregate of 4,400,000 shares.
17
Stock Option Plans
A summary of activity for the Company’s stock option plans for the three months ended March 31, 2021 is as follows:
|
|
|
Number Outstanding |
|
|
Average Exercise Price per Share |
|
|
Weighted Average Remaining Contractual Term (Years) |
|
|
Aggregate Intrinsic Value |
|
||||
|
Balance at December 31, 2020 |
|
|
550,769 |
|
|
$ |
5.56 |
|
|
|
4.88 |
|
|
$ |
1,875,719 |
|
|
Granted |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Cancelled or Expired |
|
|
(292 |
) |
|
|
14.40 |
|
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(5,254 |
) |
|
|
6.50 |
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2021 |
|
|
545,223 |
|
|
$ |
5.53 |
|
|
|
4.68 |
|
|
$ |
3,318,621 |
|
|
Vested or expected to vest at March 31, 2021 |
|
|
545,223 |
|
|
$ |
5.53 |
|
|
|
4.68 |
|
|
$ |
3,318,621 |
|
|
Exercisable at March 31, 2021 |
|
|
545,223 |
|
|
$ |
5.53 |
|
|
|
4.68 |
|
|
$ |
3,318,621 |
|
The aggregate intrinsic value in the table above represents the difference between the fair value of the Company’s common stock and the option exercise price of in-the-money options multiplied by the number of such options.
The following table summarizes information about options outstanding as of March 31, 2021:
|
|
|
Options Outstanding |
|
|
Options Exercisable |
|
||||||||||||||
|
Range of Exercise Prices |
|
Number Outstanding |
|
|
Weighted Average Remaining Contractual Life (Years) |
|
|
Weighted Average Exercise Price |
|
|
Number Exercisable |
|
|
Weighted Average Exercise Price |
|
|||||
|
$4.36 - $7.20 |
|
|
458,510 |
|
|
|
5.09 |
|
|
$ |
4.43 |
|
|
|
458,510 |
|
|
$ |
4.43 |
|
|
$7.50 - $11.25 |
|
|
66,544 |
|
|
|
2.94 |
|
|
|
10.04 |
|
|
|
66,544 |
|
|
|
10.04 |
|
|
$11.30 - $16.95 |
|
|
13,472 |
|
|
|
1.43 |
|
|
|
12.86 |
|
|
|
13,472 |
|
|
|
12.86 |
|
|
$17.60 - $26.40 |
|
|
6,697 |
|
|
|
0.49 |
|
|
|
21.55 |
|
|
|
6,697 |
|
|
|
21.55 |
|
|
$4.36 - $26.40 |
|
|
545,223 |
|
|
|
4.68 |
|
|
$ |
5.53 |
|
|
|
545,223 |
|
|
$ |
5.53 |
|
As of March 31, 2021, there was no unrecognized stock-based compensation expense related to stock options.
Restricted Stock Units
The following is a summary of RSU activity for the three months ended March 31, 2021:
|
|
|
Number Outstanding |
|
|
Weighted Average Fair Value |
|
||
|
Unvested at December 31, 2020 |
|
|
682,563 |
|
|
$ |
4.34 |
|
|
Granted |
|
|
82,151 |
|
|
|
11.18 |
|
|
Vested |
|
|
(124,558 |
) |
|
|
5.32 |
|
|
Forfeited |
|
|
(7,063 |
) |
|
|
2.93 |
|
|
Unvested at March 31, 2021 |
|
|
633,093 |
|
|
$ |
5.05 |
|
|
Shares vested but not released |
|
|
344,726 |
|
|
$ |
5.08 |
|
The fair value of the Company’s RSUs is calculated based upon the fair market value of the Company’s stock on the date of grant. As of March 31, 2021, there was $2.6 million of unrecognized compensation expense related to unvested RSUs granted, which is expected to be recognized over a weighted average period of 2.5 years.
18
Performance Stock Units
The Company granted 200,000 PSUs to a certain key employee during the year ended December 31, 2020, with a grant date fair value of $6.38 per share. The PSUs are subject to the attainment of performance goals established by the Company’s Compensation Committee, the periods during which performance is to be measured, and other limitations and conditions. Performance goals are based on pre-established objectives that specify the manner of determining the number of PSUs that will vest if performance goals are attained. If the employee terminates employment, the non-vested portion of the PSUs will not vest and all rights to the non-vested portion will terminate.
The following is a summary of PSU activity for the three months ended March 31, 2021:
|
|
|
Number Outstanding |
|
|
|
Unvested at December 31, 2020 |
|
|
200,000 |
|
|
Granted |
|
|
— |
|
|
Vested |
|
|
(20,000 |
) |
|
Forfeited |
|
|
— |
|
|
Unvested at March 31, 2021 |
|
|
180,000 |
|
As of March 31, 2021, there was $1.1 million of unrecognized compensation cost related to unvested PSUs, which is expected to be recognized over a period of 1.8 years. No tax benefit was realized from PSUs for the three months ended March 31, 2021.
Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense related to stock options, RSUs, and PSUs included in the condensed consolidated statements of comprehensive loss for the three months ended March 31, 2021 and 2020 (in thousands):
|
|
|
Three Months Ended March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Cost of revenue |
|
$ |
33 |
|
|
$ |
40 |
|
|
Research and development |
|
|
162 |
|
|
|
174 |
|
|
Selling and marketing |
|
|
103 |
|
|
|
126 |
|
|
General and administrative |
|
|
460 |
|
|
|
300 |
|
|
Total |
|
$ |
758 |
|
|
$ |
640 |
|
Restricted Stock Unit Net Share Settlements
During the three months ended March 31, 2021 and 2020, the Company repurchased 25,327 and 48,335 shares, respectively, of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of RSUs issued to employees.
19
12. Net Loss per Common Share
Basic loss per share is computed by dividing net loss, adjusted for the accretion of preferred dividends, for the period by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss for the period by the weighted average number of common shares outstanding during the period plus the dilutive effect, if any, of outstanding stock options, RSUs, PSUs, and warrants using the treasury stock method. The following table sets forth the computation of basic net loss per share:
|
|
|
Three Months Ended March 31, |
|
|||||
|
Numerator: |
|
2021 |
|
|
2020 |
|
||
|
Net loss |
|
$ |
(1,465 |
) |
|
$ |
(2,047 |
) |
|
Accretion of Series B convertible preferred stock dividends |
|
|
(284 |
) |
|
|
(270 |
) |
|
Numerator for basic net loss per share - net loss available to common stockholders |
|
$ |
(1,749 |
) |
|
$ |
(2,317 |
) |
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding - basic |
|
|
18,443 |
|
|
|
17,521 |
|
|
Net loss per common share - basic |
|
$ |
(0.09 |
) |
|
$ |
(0.13 |
) |
|
|
|
|
|
|
|
|
|
|
The following common stock equivalents have been excluded from diluted net loss per share for the three months ended March 31, 2021 and 2020 because their inclusion would have been anti-dilutive (in thousands):
|
|
|
Three Months Ended March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Shares of common stock subject to outstanding RSUs |
|
|
633 |
|
|
|
1,043 |
|
|
Shares of common stock subject to outstanding PSUs |
|
|
180 |
|
|
|
— |
|
|
Shares of common stock subject to outstanding stock options |
|
|
545 |
|
|
|
562 |
|
|
Shares of common stock subject to outstanding warrants |
|
|
275 |
|
|
|
40 |
|
|
Shares of common stock issuable upon conversion of Series B convertible preferred stock |
|
|
5,813 |
|
|
|
5,536 |
|
|
Total |
|
|
7,446 |
|
|
|
7,181 |
|
13. Segment Reporting, Geographic Information, and Concentration of Credit Risk
Segment Reporting
ASC 280, Segment Reporting (“ASC 280”) establishes standards for the reporting by public business enterprises of information about operating segments, products and services, geographic areas, and major customers. The method for determining what information to report is based on the way management organizes the operating segments within the Company for making operating decisions and assessing financial performance. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses and about which separate financial information is available to its chief operating decision makers (“CODM”). The Company’s CODM is its CEO.
The CODM reviews financial information and business performance for each operating segment. The Company evaluates the performance of its operating segments at the revenue and gross profit levels. The Company does not report total assets, capital expenditures or operating expenses by operating segment as such information is not used by the CODM for purposes of assessing performance or allocating resources.
20
Net revenue and gross profit information by segment for the three months ended March 31, 2021 and 2020 are as follows (in thousands):
|
|
|
Three Months Ended March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Identity: |
|
|
|
|
|
|
|
|
|
Net revenue |
|
$ |
13,658 |
|
|
$ |
9,886 |
|
|
Gross profit |
|
|
3,359 |
|
|
|
2,974 |
|
|
Gross profit margin |
|
|
25 |
% |
|
|
30 |
% |
|
Premises: |
|
|
|
|
|
|
|
|
|
Net revenue |
|
|
8,504 |
|
|
|
8,234 |
|
|
Gross profit |
|
|
4,333 |
|
|
|
4,526 |
|
|
Gross profit margin |
|
|
51 |
% |
|
|
55 |
% |
|
Total: |
|
|
|
|
|
|
|
|
|
Net revenue |
|
|
22,162 |
|
|
|
18,120 |
|
|
Gross profit |
|
|
7,692 |
|
|
|
7,500 |
|
|
Gross profit margin |
|
|
35 |
% |
|
|
41 |
% |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
Research and development |
|
|
2,337 |
|
|
|
2,596 |
|
|
Selling and marketing |
|
|
4,064 |
|
|
|
4,497 |
|
|
General and administrative |
|
|
2,125 |
|
|
|
2,191 |
|
|
Restructuring and severance |
|
|
388 |
|
|
|
65 |
|
|
Total operating expenses: |
|
|
8,914 |
|
|
|
9,349 |
|
|
Loss from operations |
|
|
(1,222 |
) |
|
|
(1,849 |
) |
|
Non-operating income (expense): |
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
(245 |
) |
|
|
(252 |
) |
|
Foreign currency gains (losses), net |
|
|
46 |
|
|
|
86 |
|
|
Loss before income tax provision |
|
$ |
(1,421 |
) |
|
$ |
(2,015 |
) |
Geographic Information
Geographic net revenue is based on the customer’s ship-to location. Information regarding net revenue by geographic region for the three months ended March 31, 2021 and 2020 is as follows (in thousands):
|
|
|
Three Months Ended March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Americas |
|
$ |
15,148 |
|
|
$ |
13,868 |
|
|
Europe and the Middle East |
|
|
2,460 |
|
|
|
2,601 |
|
|
Asia-Pacific |
|
|
4,554 |
|
|
|
1,651 |
|
|
Total |
|
$ |
22,162 |
|
|
$ |
18,120 |
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of net revenue: |
|
|
|
|
|
|
|
|
|
Americas |
|
|
68 |
% |
|
|
77 |
% |
|
Europe and the Middle East |
|
|
11 |
% |
|
|
14 |
% |
|
Asia-Pacific |
|
|
21 |
% |
|
|
9 |
% |
|
Total |
|
|
100 |
% |
|
|
100 |
% |
Concentration of Credit Risk
No customer accounted for 10% or more of net revenue for either of the three months ended March 31, 2021 or 2020. As of March 31, 2021, one customer accounted for 11% of accounts receivable. No customer accounted for 10% of net accounts receivable at December 31, 2020.
21
Long-lived assets by geographic location as of March 31, 2021 and December 31, 2020 are as follows (in thousands):
|
|
|
March 31, |
|
|
December 31, |
|
||
|
|
|
2021 |
|
|
2020 |
|
||
|
Property and equipment, net: |
|
|
|
|
|
|
|
|
|
Americas |
|
$ |
646 |
|
|
$ |
606 |
|
|
Europe and the Middle East |
|
|
83 |
|
|
|
73 |
|
|
Asia-Pacific |
|
|
3,039 |
|
|
|
2,148 |
|
|
Total property and equipment, net |
|
$ |
3,768 |
|
|
$ |
2,827 |
|
|
|
|
|
|
|
|
|
|
|
|
Operating lease ROU assets: |
|
|
|
|
|
|
|
|
|
Americas |
|
$ |
1,818 |
|
|
$ |
2,100 |
|
|
Europe and the Middle East |
|
|
190 |
|
|
|
224 |
|
|
Asia-Pacific |
|
|
966 |
|
|
|
1,081 |
|
|
Total operating lease right-of-use assets |
|
$ |
2,974 |
|
|
$ |
3,405 |
|
14. Restructuring and Severance
Restructuring expenses incurred during the three months ended March 31, 2021 of $388,000, consists of facility rental related costs of $329,000, which included a charge of $281,000 resulting from the impairment of a right-of-use operating lease asset for office space the Company vacated in the first quarter of 2021, and severance related costs of $59,000. Restructuring expenses incurred during the three months ended March 31, 2020 of $65,000 consists primarily of severance related costs.
15. Leases
The Company’s leases consist primarily of operating leases for administrative office space, research and development facilities, a manufacturing facility, and sales offices in various countries around the world. The Company determines if an arrangement is a lease at inception. Some lease agreements contain lease and non-lease components, which are accounted for as a single lease component. Total rent expense was approximately $0.3 million and $0.4 million for the three months ended March 31, 2021 and 2020, respectively.
Initial lease terms are determined at commencement and may include options to extend or terminate the lease when it is reasonably certain the Company will exercise the option. Remaining lease terms range from one to five years, some of which include options to extend for up to five years. Leases with an initial term of twelve months or less are not recorded on the condensed consolidated balance sheets. As the Company’s leases do not provide an implicit rate, the present value of future lease payments is determined using the Company’s incremental borrowing rate based on information available at the lease commencement date.
The table below reconciles the undiscounted cash flows for the first five years and the total of the remaining years to the operating lease liabilities recorded on the condensed consolidated balance sheet as of March 31, 2021 (in thousands):
|
|
|
March 31, |
|
|
|
|
|
2021 |
|
|
|
2021 (remaining nine months) |
|
$ |
1,112 |
|
|
2022 |
|
|
1,422 |
|
|
2023 |
|
|
486 |
|
|
2024 |
|
|
243 |
|
|
2025 |
|
|
232 |
|
|
Thereafter |
|
|
42 |
|
|
Total minimum lease payments |
|
|
3,537 |
|
|
Less: amount of lease payments representing interest |
|
|
(419 |
) |
|
Present value of future minimum lease payments |
|
|
3,118 |
|
|
Less: current liabilities under operating leases |
|
|
(1,243 |
) |
|
Long-term operating lease liabilities |
|
$ |
1,875 |
|
22
As of March 31, 2021, the weighted average remaining lease term for the Company’s operating leases was 2.8 years, and the weighted average discount rate used to determine the present value of the Company’s operating leases was 6.3%. Sublease rental income due in the future under non-cancelable subleases was $1.6 million.
Cash paid for amounts included in the measurement of operating lease liabilities was $0.4 million for the three months ended March 31, 2021. No cash was received from sublease rental income for the three months ended March 31, 2021.
16. Commitments and Contingencies
The following table summarizes the Company’s principal contractual commitments, excluding operating leases, as of March 31, 2021 (in thousands):
|
|
|
Purchase Commitments |
|
|
Other Contractual Commitments |
|
|
Total |
|
|||
|
2021 (remaining nine months) |
|
$ |
14,845 |
|
|
$ |
241 |
|
|
$ |
15,086 |
|
|
2022 |
|
|
165 |
|
|
|
— |
|
|
|
165 |
|
|
Total |
|
$ |
15,010 |
|
|
$ |
241 |
|
|
$ |
15,251 |
|
Purchase commitments for inventories are highly dependent upon forecasts of customer demand. Due to the uncertainty in demand from its customers, the Company may have to change, reschedule, or cancel purchases or purchase orders from its suppliers. These changes may lead to vendor cancellation charges on these purchases or contractual commitments.
The following table summarizes the Company’s warranty accrual account activity during the three months ended March 31, 2021 and 2020:
|
|
|
Three Months Ended March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Balance at beginning of period |
|
$ |
321 |
|
|
$ |
399 |
|
|
Accruals for warranties charged to expense |
|
|
16 |
|
|
|
9 |
|
|
Cost of warranty claims |
|
|
(2 |
) |
|
|
(22 |
) |
|
Balance at end of period |
|
$ |
335 |
|
|
$ |
386 |
|
The Company provides warranties on certain product sales for periods ranging from 12 to 36 months, and allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have been immaterial.
17. Subsequent Events
On April 7, 2021, the Company sold an aggregate of 3,779,342 shares of its common stock at a public offering price of $10.65 per share in an underwritten public offering. The Company received net proceeds of approximately $37.9 million from the sale of the common stock in the public offering, after deducting the underwriting discount and other offering related expenses of $2.3 million.
There were no other subsequent events except as disclosed within Note 8, Financial Liabilities.
23
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and other parts of this Quarterly Report on Form 10-Q (“Quarterly Report”) contain forward-looking statements, within the meaning of the safe harbor provisions under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties. Forward-looking statements reflect current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as “will,” “believe,” “could,” “should,” “would,” “may,” “anticipate,” “intend,” “plan,” “estimate,” “expect,” “project” or the negative of these terms or other similar expressions. Forward-looking statements are not guarantees of future performance and our actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part II, Item 1A of this Report and in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020 under the heading “Risk Factors,” The following discussion should be read in conjunction with the audited consolidated financial statements and notes thereto included in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2020. We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law.
Each of the terms the “Company,” “Identiv,” “we” and “us” as used herein refers collectively to Identiv, Inc. and its wholly-owned subsidiaries, unless otherwise stated.
Overview
Identiv is a global provider of secure identification and physical security.
We are leveraging our Radio Frequency Identification (“RFID”) based physical device-management expertise as well as our physical access, video and analytics solutions to provide leading solutions as our customers, and our customers’ customers, embracing the Internet of Things (“IoT”). Customers in the technology and mobility, consumer, government, healthcare, education and other sectors rely on Identiv’s identification and access solutions. Identiv’s platform encompasses RFID and Near-Field Communication (“NFC”), cybersecurity, and the full spectrum of physical access, video, and audio security. We are bringing the benefits of the IoT to a wide range of physical, connected items.
Identiv’s mission is to digitally enable every physical thing and every physical place on the planet. Our full continuum of security solutions is delivered through our platform of RFID enabled devices, mobile, client/server, cloud, web, dedicated hardware and software defined architectures. In doing so, we believe that we will create smart physical security and a smarter physical world.
Segments
We have organized our operations into two reportable business segments, principally by solution families: Identity and Premises. Our Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber-security market, and protecting connected objects and information using RFID embedded security. Our Premises segment includes our solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, audio, access readers and identities.
Factors Affecting Our Performance
Market Adoption
Our financial performance depends on the pace, scope and depth of end-user adoption of our RFID products in multiple industries. That pace, scope and depth accelerated during 2020 causing large fluctuations in our operating results. For example, in 2019 our Identity segment experienced a reduction from 2018 overall with modest gains in our RFID business offset by lower access card revenue. During 2020, we saw several events that we believe are opening up the third wave of RFID deployments which is occurring at a much faster pace of growth than historically. We believe significant improvement in chip capabilities at lower costs, combined with the incorporation of the full NFC Data Exchange Format (“NDEF”) protocol by Apple in its iPhone 12 and iOS 14 has accelerated the opportunities for product engineers to integrate RFID into their products to create new and more engaging customer experiences, product reliability and performance. As the market hit this pivot point, we expanded both our capacity and technical leadership. We track growth indicators including design wins, customer launches and technology launches. We have made investments in our technology, world class quality and automation, and we believe that our competitive advantages will continue to drive growth.
We believe the underlying, long-term trend is continued RFID adoption by multiple verticals. We also believe that expanding use cases fosters adoption across verticals and into other markets. In addition, we do not have any significant concentration of customers so we believe that our demand will continue to be resilient to the loss of any individual customer or application.
24
If RFID market adoption, and adoption of our products specifically, does not meet our expectations then our growth prospects and operating results will be adversely affected. If we are unable to meet end-user or customer volume or performance expectations, then our business prospects may be adversely affected. In contrast, if our RFID sales exceed expectations, then our revenue and profitability may be positively affected.
Given the uncertainties of the specific timing of our new customer deployments, we cannot assure you that we have appropriate inventory and capacity levels or that we will not experience inventory shortfalls or overages in the future. We mitigate those risks by being deeply embedded in our customers design cycle, working with our chip partners on long lead time components, managing our limited capital equipment needs within a short cycle and future proofing our facilities with the most recent expansion to accommodate several scenarios for growth potential.
If end users with sizable projects change or delay them, we may experience significant fluctuation in revenue on a quarterly or annual basis, and we anticipate that uncertainty to continue to characterize our business for the foreseeable future.
Seasonality and Other Factors
In our business overall, we may experience variations in demand for our offerings from quarter to quarter, and typically experience a stronger demand cycle in the second half of our fiscal year. Sales of our physical access control solutions and related products to U.S. Government agencies are subject to annual government budget cycles and generally are highest in the third quarter of each year. Sales of our identity readers, many of which are sold to government agencies worldwide, are impacted by project schedules of government agencies, as well as roll-out schedules for application deployments. Further, this business is typically subject to seasonality based on differing commercial and global government budget cycles. Lower sales are expected in the U.S. in the first half, and in particular, the first quarter of the year, with higher sales typically in the second half of each year. In Asia-Pacific, with fiscal year-ends in March and June, order demand can be higher in the first quarter as customers attempt to complete projects before the end of the fiscal year. Accordingly, our net revenue levels in the first quarter each year often depend on the relative strength of project completions and sales mix between our U.S. customer base and our international customer base.
Purchasing of our Products and Services for U.S. Federal Government Security Programs
In addition to the general seasonality of demand, overall U.S. Federal Government expenditure patterns have a significant effect on demand for our products due to the significant portion of revenue that are typically sourced from U.S. Federal Government agencies. Drivers of growth included our technology strength and proven security solutions, work from home mandates, and continued strength in investments for security across a number of different agencies. We believe that the success and growth of our business will continue through the U.S. Federal Government focus on security and our successful procurement of government business. If there are changes in government purchasing policies or budgetary constraints there could be implications for our growth prospects and operating results. If we are unable to meet end-user or customer volume or performance expectations, then our business prospects may be adversely affected.
Effects of the COVID-19 Pandemic on our Business.
In March 2020, the World Health Organization characterized the coronavirus (“COVID-19”) a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. The rapid spread of the pandemic and the continuously evolving responses to combat it have had an increasingly negative impact on the global economy. In view of the rapidly changing business environment created by the uncertainty related to the depth and or duration of the impact resulting from COVID-19, we have experienced delays in our sales in select vertical markets and are currently unable to determine if there will be any continued disruption and the extent to which this may have future impact on our business. We continue to monitor the progression of the pandemic and its effect on our financial position, results of operations, and cash flows.
25
Results of Operations
The following table includes net revenue and net profit information by business segment and reconciles gross profit to loss before income taxes (in thousands).
|
|
|
Three Months Ended March 31, |
|
|||||||||
|
|
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
Identity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue |
|
$ |
13,658 |
|
|
$ |
9,886 |
|
|
|
38 |
% |
|
Gross profit |
|
|
3,359 |
|
|
|
2,974 |
|
|
|
13 |
% |
|
Gross profit margin |
|
|
25 |
% |
|
|
30 |
% |
|
|
|
|
|
Premises: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue |
|
|
8,504 |
|
|
|
8,234 |
|
|
|
3 |
% |
|
Gross profit |
|
|
4,333 |
|
|
|
4,526 |
|
|
|
(4 |
%) |
|
Gross profit margin |
|
|
51 |
% |
|
|
55 |
% |
|
|
|
|
|
Total: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue |
|
|
22,162 |
|
|
|
18,120 |
|
|
|
22 |
% |
|
Gross profit |
|
|
7,692 |
|
|
|
7,500 |
|
|
|
3 |
% |
|
Gross profit margin |
|
|
35 |
% |
|
|
41 |
% |
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
2,337 |
|
|
|
2,596 |
|
|
|
(10 |
%) |
|
Selling and marketing |
|
|
4,064 |
|
|
|
4,497 |
|
|
|
(10 |
%) |
|
General and administrative |
|
|
2,125 |
|
|
|
2,191 |
|
|
|
(3 |
%) |
|
Restructuring and severance |
|
|
388 |
|
|
|
65 |
|
|
N/A |
|
|
|
Total operating expenses: |
|
|
8,914 |
|
|
|
9,349 |
|
|
|
(5 |
%) |
|
Loss from operations |
|
|
(1,222 |
) |
|
|
(1,849 |
) |
|
|
(34 |
%) |
|
Non-operating income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
(245 |
) |
|
|
(252 |
) |
|
|
(3 |
%) |
|
Foreign currency gains (losses), net |
|
|
46 |
|
|
|
86 |
|
|
|
(47 |
%) |
|
Loss before income taxes |
|
$ |
(1,421 |
) |
|
$ |
(2,015 |
) |
|
|
(29 |
%) |
Geographic net revenue based on each customer’s ship-to location is as follows (in thousands):
|
|
|
Three Months Ended March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Americas |
|
$ |
15,148 |
|
|
$ |
13,868 |
|
|
Europe and the Middle East |
|
|
2,460 |
|
|
|
2,601 |
|
|
Asia-Pacific |
|
|
4,554 |
|
|
|
1,651 |
|
|
Total |
|
$ |
22,162 |
|
|
$ |
18,120 |
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of net revenue: |
|
|
|
|
|
|
|
|
|
Americas |
|
|
68 |
% |
|
|
77 |
% |
|
Europe and the Middle East |
|
|
11 |
% |
|
|
14 |
% |
|
Asia-Pacific |
|
|
21 |
% |
|
|
9 |
% |
|
Total |
|
|
100 |
% |
|
|
100 |
% |
Net Revenue
Net revenue for the three months ended March 31, 2021 was $22.2 million, an increase of 22% compared with $18.1 million for the comparable period of 2020. Net revenue in the Americas was $15.1 million for the three months ended March 31, 2021, an increase of 9% compared to $13.9 million for the comparable period of 2020. Net revenue from our Premises solution for security programs within various U.S. government agencies and commercial customers for access control and video solutions, as well as reader, controller and appliance products, represented approximately 51% of our net revenue in the Americas. Net revenue in Europe, the Middle East, and Asia-Pacific was approximately $7.0 million for the three months ended March 31, 2021, an increase of 65% compared with the comparable period of 2020. Sales of RFID and NFC products and smart card readers comprise a significant proportion of our net revenue in these regions.
26
Net revenue in our Identity segment, which represented 62% of our net revenue, was $13.7 million for the three months ended March 31, 2021, an increase of 38% compared with $9.9 million for the comparable period of 2020. Net revenue in this segment in the Americas for the three months ended March 31, 2021 increased 16% compared with the comparable period of 2020 primarily due to higher sales of RFID transponder products and smart card readers. The primary driver of higher sales of our RFID transponder products was the broad adoption of NFC, and the continued demand for smart card reader products with shelter in place actions driving the need for more work from home technologies. Net revenue in this segment in Europe, the Middle East, and the Asia-Pacific increased approximately 80% for the three months ended March 31, 2021 compared with the comparable period of 2020 due to higher sales of RFID transponder products and smart card readers. RFID transponder products comprised approximately 63% of net revenue in these regions for the three months ended March 31, 2021, and 45% of net revenue for the three months ended March 31, 2020, while smart card reader sales for the three months ended March 31, 2021 and 2020 comprised approximately 24% and 36% of the net revenue.
Net revenue in our Premises segment, which represented 38% of our net revenue, was $8.5 million for the three months ended March 31, 2021, an increase of 3% compared with $8.2 million for the comparable period of 2020. Net revenue in this segment in the Americas for the three months ended March 31, 2021 increased 4% compared with the comparable period of 2020 primarily due to higher Hirsch Velocity software product sales and related support services, particularly in the federal government, partially offset by lower sales of video technology and analytics software products and related support services. Net revenue in this segment across Europe, the Middle East, and Asia-Pacific was comparable to the comparable period of 2020.
As a general trend, U.S. Federal agencies continue to be subject to security improvement mandates under programs such as Homeland Security Presidential Directive-12 (“HSPD-12”) and reiterated in memoranda from the Office of Management and Budget (“OMB M-11-11”). We believe that our solutions for trusted physical access is an attractive offering to help federal agency customers move towards compliance with federal directives and mandates. To address sales opportunities in the United States in general and with our U.S. Government customers in particular, we focus on a strong U.S. sales organization and our sales presence in Washington D.C.
More recently, in response to the new needs for health and safety in the physical security market overall, due to the COVID-19 pandemic, we have released products to address these trends. During 2020, we launched our contact tracing downloadable extension for our Velocity access system, our occupancy tracking system based on our 3VR platform, our MobilisID touchless reader and our temperature tracking tag. In addition, with the economic impact of the COVID-19 pandemic creating more uncertainty for our customers, we have released several products which are subscription based and which allow payments over time for our physical access and video solutions as a service.
Gross Profit and Gross Margin
Gross profit for the three months ended March 31, 2021 was $7.7 million, or 35% of net revenue, compared with $7.5 million, or 41% of net revenue in the comparable period of 2020. Gross profit represents net revenue less direct cost of product sales, manufacturing overhead, other costs directly related to preparing the product for sale including freight, scrap, inventory adjustments and amortization, where applicable.
In our Identity segment, gross profit was $3.4 million in the three months ended March 31, 2021 compared with $3.0 million in the comparable period of 2020. Gross profit margins in the Identity segment decreased to 25% in the three months ended March 31, 2021 from 30% in the comparable period of 2020 primarily due to the change in product mix, with a higher proportion of lower margin RFID transponder product sales.
In our Premises segment, gross profit was $4.3 million in the three months ended March 31, 2021 compared with $4.5 million in the comparable period of 2020. Gross profit margins in the Premises segment decreased to 51% in the three months ended March 31, 2021 from 55% in the comparable period of 2020 primarily due to product mix, with lower sales of higher margin video analytics software and services compared to the comparable period in 2020.
We expect there will be variation in our total gross profit from period to period, as our gross profit has been and will continue to be affected primarily by varying mix among our products. Within each product category, gross margins have tended to be consistent, but over time may be affected by a variety of factors, including, without limitation, competition, product pricing, the volume of sales in any given quarter, manufacturing volumes, product configuration and mix, the availability of new products, product enhancements, software and services, risk of inventory write-downs and the cost and availability of components.
Operating Expenses
Information about our operating expenses for the three months ended March 31, 2021 and 2020 is set forth below (dollars in thousands).
27
Research and Development
|
|
|
Three Months Ended March 31, |
|
|||||||||
|
|
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
Research and development |
|
$ |
2,337 |
|
|
$ |
2,596 |
|
|
|
(10 |
%) |
|
as a % of net revenue |
|
|
11 |
% |
|
|
14 |
% |
|
|
|
|
Research and development expenses consist primarily of employee compensation and fees for the development of hardware, software and firmware products. We focus the bulk of our research and development activities on the continued development of existing products and the development of new offerings for emerging market opportunities.
Research and development expenses for the three months ended March 31, 2021 decreased compared to the comparable prior year period primarily due to lower headcount and related costs, partially offset by higher external contractor costs.
Selling and Marketing
|
|
|
Three Months Ended March 31, |
|
|||||||||
|
|
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
Selling and marketing |
|
$ |
4,064 |
|
|
$ |
4,497 |
|
|
|
(10 |
%) |
|
as a % of net revenue |
|
|
18 |
% |
|
|
25 |
% |
|
|
|
|
Selling and marketing expenses consist primarily of employee compensation as well as amortization expense of certain intangible assets, customer lead generation activities, tradeshow participation, advertising and other marketing and selling costs.
Selling and marketing expenses for the three months ended March 31, 2021 decreased compared to the comparable prior year period primarily due to lower amortization expense associated with intangible assets that were fully amortized in the fourth quarter of 2020, and higher recruiting fees in the three months ended March 31, 2020.
General and Administrative
|
|
|
Three Months Ended March 31, |
|
|||||||||
|
|
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
General and administrative |
|
$ |
2,125 |
|
|
$ |
2,191 |
|
|
|
(3 |
%) |
|
as a % of net revenue |
|
|
10 |
% |
|
|
12 |
% |
|
|
|
|
General and administrative expenses consist primarily of compensation expenses for employees performing administrative functions, and professional fees incurred for legal, auditing and other consulting services.
General and administrative expense for the three months ended March 31, 2021 decreased compared to the prior year period primarily due to reductions in headcount and related costs associated with our continued integration efforts across general and administrative functions.
Restructuring and Severance Charges
|
|
|
Three Months Ended March 31, |
||||||||
|
|
|
2021 |
|
|
2020 |
|
|
% Change |
||
|
Restructuring and severance |
|
$ |
388 |
|
|
$ |
65 |
|
|
N/A |
Restructuring expenses incurred during the three months ended March 31, 2021 of $388,000, consists of facility rental related costs of $329,000, which included a charge of $281,000 resulting from the impairment of a right-of-use operating lease asset for office space we vacated in the first quarter of 2021, and severance related costs of $59,000. Restructuring expenses incurred during the three months ended March 31, 2020 of $65,000 consist primarily of severance related costs.
See Note 14, Restructuring and Severance, in the accompanying notes to our unaudited condensed consolidated financial statements for more information.
28
Non-operating Income (Expense)
Information about our non-operating income (expense) for the three months ended March 31, 2021 and 2020 is set forth below (dollars in thousands).
|
|
|
Three Months Ended March 31, |
|
|||||||||
|
|
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
Interest expense, net |
|
$ |
(245 |
) |
|
$ |
(252 |
) |
|
|
(3 |
%) |
|
Foreign currency gains (losses), net |
|
$ |
46 |
|
|
$ |
86 |
|
|
|
(47 |
%) |
Interest expense, net consists of interest on financial liabilities, amortization of debt issuance costs, and interest accretion expense for a liability on a contractual payment obligation arising from our acquisition of Hirsch Electronics Corporation.
The decrease in interest expense for the three months ended March 31, 2021 compared to the comparable period of 2020 was primarily attributable to lower borrowings outstanding under our revolving loan facility with our lender. See Note 7, Contractual Payment Obligation and Note 8, Financial Liabilities, in the accompanying notes to our unaudited condensed consolidated financial statements for more information.
Changes in currency valuation in the periods mainly were the result of exchange rate movements between the U.S. dollar, the Indian Rupee, the Canadian dollar, and the euro. Our foreign currency gains and losses primarily result from the valuation of current assets and liabilities denominated in a currency other than the functional currency of the respective entity in the local financial statements.
Income Tax Provision
|
|
|
Three Months Ended March 31, |
|
|||||||||
|
|
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
Income tax provision |
|
$ |
(44 |
) |
|
$ |
(32 |
) |
|
|
38 |
% |
|
Effective tax rate |
|
|
(3 |
%) |
|
|
(2 |
%) |
|
|
|
|
As of March 31, 2021, our deferred tax assets are fully offset by a valuation allowance. Accounting Standards Codification (“ASC”) 740, Income Taxes, provides for the recognition of deferred tax assets if realization of such assets is more-likely-than-not. Based upon the weight of available evidence, which includes historical operating performance, reported cumulative net losses since inception and difficulty in accurately forecasting our future results, we provided a full valuation allowance against all of our net U.S. and foreign deferred tax assets. We reassess the need for our valuation allowance on a quarterly basis. If it is later determined that a portion or all of the valuation allowance is not required, it generally will be a benefit to the income tax provision in the period such determination is made.
We recorded an income tax provision during the three months ended March 31, 2021. The effective tax rates for the three months ended March 31, 2021 and 2020 differ from the federal statutory rate of 21% primarily due to a change in valuation allowance, and the provision or benefit in certain foreign jurisdictions, which are subject to higher tax rates.
Liquidity and Capital Resources
As of March 31, 2021, our working capital, defined as current assets less current liabilities, was $10.1 million, a decrease of $1.8 million compared to $11.9 million as of December 31, 2020. As of March 31, 2021, our cash balance was $11.5 million.
Sale of Common Stock
On April 7, 2021, we sold an aggregate of 3,779,342 shares of our common stock at a public offering price of $10.65 per share in an underwritten public offering. We received net proceeds of approximately $37.9 million from the sale of the common stock in the public offering, after deducting the underwriting discount and other offering related expenses of $2.3 million.
East West Bank
On February 8, 2017, we entered into a loan and security agreement with East West Bank (“EWB”). Following subsequent amendments, on February 8, 2021 we amended and restated the Loan and Security Agreement in its entirety (the “Loan and Security Agreement”). The Loan and Security Agreement provides for a $20.0 million revolving loan facility subject to a borrowing base and a $4.0 million non-formula revolving loan facility that is not subject to a borrowing base. Our obligations under the Loan and Security Agreement are collateralized by substantially all of our assets.
29
The maturity date of the main revolving loan facility is February 8, 2023. The non-formula revolving loan facility will terminate on February 7, 2022, however we may, at our option if certain conditions are met, convert prior to their maturity any loans under the non-formula revolving loan facility to a term loan that will fully amortize and mature on February 1, 2025. Advances under the revolving loan facilities and the term loan (if converted) will initially bear interest at a per annum rate equal to the prime rate as determined under the Loan and Security Agreement plus 0.25%. On April 30, 2021, we entered into an amendment to our Loan and Security Agreement which reduced the per annum interest rate to the prime interest rate.
We may voluntarily prepay amounts outstanding under the revolving loan facilities and the term loan without prepayment charges. In the event the Loan and Security Agreement is terminated prior to February 8, 2023, we would be required to pay an early termination fee in the amount of 2.0% of the main revolving loan line if terminated prior to February 8, 2022 and 1% of the main revolving loan line thereafter. Additional borrowing requests under the revolving loan facilities are subject to various customary conditions precedent, including a borrowing base for the main revolving loan facility.
The Loan and Security Agreement contains customary representations and warranties and customary affirmative and negative covenants, including, limits or restrictions on our ability to incur liens, incur indebtedness, make certain restricted payments (including dividends), merge or consolidate and dispose of assets. In addition, the Loan and Security Agreement contains financial covenants requiring that we (i) hold $5 million in unrestricted cash in accounts with EWB, (ii) maintain a monthly minimum trailing six-month EBITDA of $0.6 million for the first two quarters of 2021 and $1.2 million thereafter and (iii) maintain, if we convert into the term loan and starting with the quarter ending March 31, 2022, a quarterly fixed charge coverage ratio of at least 1.35 : 1.00.
The Loan and Security Agreement contains customary events of default that entitle EWB to cause any or all of our indebtedness under it to become immediately due and payable. The events of default (some of which are subject to applicable grace or cure periods), include, among other things, non-payment defaults, covenant defaults, cross-defaults to other material indebtedness, bankruptcy and insolvency defaults and material judgment defaults. Upon the occurrence and during the continuance of an event of default, EWB may terminate its lending commitment and/or declare all or any part of the unpaid principal of all loans, all interest accrued and unpaid thereon and all other amounts payable under the Loan and Security Agreement to be immediately due and payable.
See Note 8, Financial Liabilities and Note 10, Stockholders’ Equity in the accompanying notes to our unaudited condensed consolidated financial statements for more information.
April 21 Funds
On May 5, 2020, we issued secured subordinated promissory notes in an aggregate principal amount of $4.0 million (the “Notes”) to 21 April Fund, LP and 21 April Fund, Ltd. (collectively referred to as the “April 21 Funds”) pursuant to a Note and Warrant Purchase Agreement entered into with the April 21 Funds (the “Note Purchase Agreement”). The Notes are collateralized by our assets, but subordinate to our obligations to EWB under the Loan and Security Agreement. Proceeds from the sale of the Notes were only to be used for expenses incurred by us in connection with our provisions of goods and services under a statement of work with a third party. The Notes have an initial term of nine months and do not bear interest during this period. However, if the Notes are not repaid on or before the nine-month anniversary of issuance, (a) the Notes will thereafter bear interest of 8% per annum, payable quarterly, and (b) additional warrants to purchase common stock would be issuable to the April 21 Funds for each month all or a portion of the Notes remain unpaid. In the event the Notes are not paid in full by the first anniversary of their issuance, May 5, 2021, they shall thereafter bear interest of 12% per annum, payable quarterly, and additional warrants would be issuable to the April 21 Funds.
On February 5, 2021, we entered into an amendment to our secured subordinated promissory note with April 21 Funds, which extended the initial term of the Notes to March 31, 2021. As a result of the amendment, if the Notes are repaid on or before March 31, 2021, we will incur no further interest on the Notes, or be obligated to issue additional warrants. As of March 31, 2021, the principal amount outstanding under the Notes was $2.8 million.
On March 31, 2021, April 21 Funds waived any additional warrants issuable, and interest payable, to April 21 Funds through May 5, 2021. On April 13, 2021, we repaid the remaining principal amount outstanding of $2.8 million.
30
Paycheck Protection Program
On April 9, 2020, we entered into a promissory note (the PPP Note”) under the Paycheck Protection Program established under Section 1102 of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act. The PPP Note is dated April 8, 2020 with EWB. We borrowed a principal amount of approximately $2.9 million. The interest on the PPP Note is 1.0% per annum. The PPP Note is payable two years from the date of the PPP Note, and there is no prepayment penalty. All interest which accrues during the initial six months of the loan period is deferred and payable on the maturity date of the PPP Note. Notes issued under the CARES Act may be eligible for forgiveness in whole or in part in accordance with Small Business Administration rules established for the Paycheck Protection Program. The principal amount outstanding, including accrued interest, is included in current portion – financial liabilities and other accrued expenses and liabilities in the accompanying consolidated balance sheets, as we expect all amounts outstanding will be forgiven in 2021.
As our previously unremitted earnings have been subjected to U.S. federal income tax, we expect any repatriation of these earnings to the U.S. would not incur significant additional taxes related to such amounts. However, our estimates are provisional and subject to further analysis. Generally, most of our foreign subsidiaries have accumulated deficits and cash and cash equivalents that are held outside the United States are typically not cash generated from earnings that would be subject to tax upon repatriation if transferred to the United States. We have access to the cash held outside the United States to fund domestic operations and obligations without any material income tax consequences. As of March 31, 2021, the amount of cash included at such subsidiaries was $1.6 million. We have not, nor do we anticipate the need to, repatriate funds to the United States to satisfy domestic liquidity needs arising in the ordinary course of business, including liquidity needs associated with our domestic debt service requirements.
We have historically incurred operating losses and negative cash flows from operating activities, and we may continue to incur losses in the future. As of March 31, 2021, we had a total accumulated deficit of $412.1 million. During the three months ended March 31, 2021, we had a net loss of $1.5 million.
We believe our existing cash balance, together with cash generated from operations and available credit under our Loan and Security Agreement, as well as the $37.9 million net proceeds received in our underwritten public offering in April 2021, will be sufficient to satisfy our working capital needs to fund operations for the next twelve months. We may also use cash to acquire or invest in complementary businesses, technologies, services or products that would change our cash requirements. We may also choose to finance our business through public or private equity offerings, debt financings or other arrangements. However, there can be no assurance that additional capital will be available to us or that such capital will be available to us on acceptable terms. If we raise funds by issuing equity securities, dilution to stockholders could result. Debt or any equity securities issued also may provide for rights, preferences or privileges senior to those of holders of our common stock. The terms of debt securities issued or borrowings could impose significant restrictions on our operations. The incurrence of additional indebtedness or the issuance of certain debt or equity securities could result in increased fixed payment obligations and could also result in restrictive covenants, such as limitations on our ability to incur additional debt or issue additional equity, limitations on our ability to acquire or license intellectual property rights and other operating restrictions that could adversely affect our ability to conduct our business. Our Loan and Security Agreement imposes restrictions on our operations, increases our fixed payment obligations and has restrictive covenants. In addition, the issuance of additional equity securities by us, or the possibility of such issuance, may cause the market price of our common stock to decline. If we are not able to secure additional funding when needed, we may have to curtail or reduce the scope of our business or forgo potential business opportunities.
The following summarizes our cash flows for the three months ended March 31, 2021 and 2020 (in thousands):
|
|
|
March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
||
|
Net cash used in operating activities |
|
$ |
(411 |
) |
|
$ |
(3,709 |
) |
|
Net cash used in investing activities |
|
|
(1,131 |
) |
|
|
(137 |
) |
|
Net cash provided by financing activities |
|
|
1,963 |
|
|
|
3,412 |
|
|
Effect of exchange rates on cash and cash equivalents |
|
|
(312 |
) |
|
|
(253 |
) |
|
Net increase (decrease) in cash and cash equivalents |
|
|
109 |
|
|
|
(687 |
) |
|
Cash and cash equivalents at beginning of period |
|
|
11,409 |
|
|
|
9,383 |
|
|
Cash and cash equivalents at end of period |
|
$ |
11,518 |
|
|
$ |
8,696 |
|
31
Cash flows from operating activities
Cash used in operating activities for the three months ended March 31, 2021 was primarily due to net loss of $1.5 million, a decrease in cash from net changes in operating assets and liabilities of $0.5 million, and adjustments for certain non-cash items of $1.6 million, consisting primarily of depreciation, amortization, amortization of debt issuance costs, stock-based compensation, and impairment of a right-of-use operating lease asset.
Cash used in operating activities for the three months ended March 31, 2020 was primarily due to net loss of $2.0 million, a decrease in cash from net changes in operating assets and liabilities of $3.2 million, and adjustments for certain non-cash items of $1.5 million, consisting primarily of depreciation, amortization, amortization of debt issuance costs, and stock-based compensation.
Cash flows from investing activities
Cash used in investing activities for the three months ended March 31, 2021 and 2020 was $1.1 million and $0.1 million, respectively, which related to capital expenditures.
Cash flows from financing activities
Cash provided by financing activities during the three months ended March 31, 2021 was primarily due to net borrowings under our revolving loan facility of $2.2 million, partially offset by taxes paid related to net share settlement of restricted stock units of $0.3 million.
Cash provided by financing activities during the three months ended March 31, 2020 was primarily due to net borrowings under our revolving loan and term loan facilities of $3.6 million, partially offset by taxes paid related to net share settlement of restricted stock units of $0.2 million.
Off-Balance Sheet Arrangements
We have not entered into off-balance sheet arrangements, or issued guarantees to third parties, except as disclosed in Note 7, Contractual Payment Obligation.
Critical Accounting Policies and Estimates
Our condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of these financial statements requires management to establish accounting policies that contain estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These policies relate to revenue recognition, inventory, income taxes, goodwill, intangible and long-lived assets and stock-based compensation. We have other important accounting policies and practices; however, once adopted, these other policies either generally do not require us to make significant estimates or assumptions or otherwise only require implementation of the adopted policy and not a judgment as to the policy itself. Management bases its estimates and judgments on historical experience and on various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Despite our intention to establish accurate estimates and assumptions, actual results may differ from these estimates under different assumptions or conditions.
During the three months ended March 31, 2021, management believes there have been no significant changes to the items that we disclosed within our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2020.
Recent Accounting Pronouncements
See Note 2, Significant Accounting Policies and Recent Accounting Pronouncements, in the accompanying notes to our unaudited condensed consolidated financial statements in Item 1 of Part I of this Quarterly Report for a description of recent accounting pronouncements, which is incorporated herein by reference.
32
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Not required.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, or Exchange Act, that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Our disclosure controls and procedures have been designed to meet reasonable assurance standards. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Based on their evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Controls over Financial Reporting
We have made no changes to our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the three months ended March 31, 2021, that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.
33
From time to time, we may become subject to claims arising in the ordinary course of business or could be named a defendant in lawsuits. The outcome of such claims or other proceedings cannot be predicted with certainty and may have a material effect on our financial condition, results of operations or cash flows.
Our business and results of operations are subject to numerous risks, uncertainties, and other factors that you should be aware of. You should carefully review and consider the information regarding certain factors that could materially affect our business, financial condition or future results set forth under Part I - Item 1A (Risk Factors) in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020. Other than as discussed below, there have been no material changes from the risk factors disclosed in our 2020 Annual Report on Form 10-K. The risks, uncertainties and other factors described in the risk factors are not the only ones facing our company. Additional risks, uncertainties and other factors not presently known to us or that we currently deem immaterial may also impair our business operations. Any of the risks, uncertainties and other factors could have a materially adverse effect on our business, financial condition, results of operations, cash flows or product market share and could cause the trading price of our common stock to decline substantially.
We depend on a number of suppliers and contract manufacturers for the production of our products and components making us potentially vulnerable to supply disruption.
Our reliance on suppliers and contract manufacturers for the production of our products and hardware components could result in product delivery problems and delays. We may suffer a disruption if the supply of components causes us to be unable to purchase sufficient components on a timely basis. For example, the global semiconductor shortage in 2021 may adversely impact our ability to meet product demand in a timely fashion. This shortage, which is due in part to COVID-19, may persist for an indefinite period of time and could have a negative impact on our revenue and operating results. Low inventory levels can affect our ability to meet customer demand, lengthen lead times and potentially cause us to miss opportunities, lose market share and/or damage customer relationships, also adversely affecting our business. Although we have taken steps to insure we have adequate supply for expected customer demand, there can be no assurance that our efforts will be successful. If we are not able to get the necessary products and components on a timely basis, our business, financial condition and results of operations may be adversely affected.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
During the three months ended March 31, 2021 and 2020, we repurchased 25,327 shares and 48,335 shares, respectively, of common stock surrendered to us to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees.
34
|
Exhibit Number |
|
Description |
|
|
|
|
|
10.1^ |
|
Waiver Under Note and Warrant Purchase Agreement, dated as of March 31, 2021. |
|
|
|
|
|
31.1^ |
|
|
|
|
|
|
|
31.2^ |
|
|
|
|
|
|
|
32# |
|
|
|
|
|
|
|
101.INS |
|
XBRL Instance Document |
|
|
|
|
|
101.SCH |
|
XBRL Taxonomy Extension Schema Document |
|
|
|
|
|
101.CAL |
|
XBRL Taxonomy Extension Calculation Linkbase Document |
|
|
|
|
|
101.DEF |
|
XBRL Taxonomy Extension Definition Linkbase Document |
|
|
|
|
|
101.LAB |
|
XBRL Taxonomy Extension Label Linkbase Document |
|
|
|
|
|
101.PRE |
|
XBRL Taxonomy Extension Presentation Linkbase Document |
|
# |
Furnished herewith and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933 or the Exchange Act, except to the extent that the registrant specifically incorporates them by reference. |
|
^ |
Filed herewith. |
35
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
IDENTIV, INC. |
||
|
|
|
|
|
|
|
May 10, 2021 |
|
By: |
|
/S/ Steven Humphreys |
|
|
|
|
|
Steven Humphreys |
|
|
|
|
|
Chief Executive Officer |
|
|
|
|
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
May 10, 2021 |
|
By: |
|
/S/ Sandra Wallach |
|
|
|
|
|
Sandra Wallach |
|
|
|
|
|
Chief Financial Officer and Secretary |
|
|
|
|
|
(Principal Financial and Accounting Officer) |
36
Exhibit 10.1
WAIVER UNDER NOTE AND WARRANT PURCHASE AGREEMENT
THIS WAIVER UNDER NOTE AND WARRANT PURCHASE AGREEMENT (this “Waiver”) is entered into as of March 31, 2021 by and between Identiv, Inc., a Delaware corporation (the “Company”), 21 April Fund, Ltd. (the “Holder”) and 21 April Fund, LP. Capitalized terms not defined herein have the meanings ascribed to them in the Purchase Agreement (as defined below).
WHEREAS, on May 5, 2020, the Company, 21 April Fund, LP and the Holder entered into a Note and Warrant Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company issued a Secured Subordinated Promissory Note to each of 21 April Fund, LP (the “21 April Fund, LP Note”) and to the Holder (the “Holder Note”);
WHEREAS, on December 30, 2020, the Company repaid in full the 21 April Fund, LP Note, and on February 5, 2021, the Company and Holder entered into an amendment to the Holder Note;
WHEREAS, the Company has advised the Holder that it desires to extend the maturity date of the Holder Note to May 5, 2021 (the “Extended Maturity Date”), as permitted by Section 1.2 of the Holder Note;
WHEREAS, the Holder has advised the Company that it desires to waive (a) the issuance of Extension Warrants that would otherwise be issuable to the Holder under Section 5.3(b) of the Purchase Agreement as a result of such extension and (b) the interest at the rate of 8% per annum that would otherwise accrue under the Holder Note during the period from the end of the Initial Maturity Date through the Extended Maturity Date but not waive, for the avoidance of doubt, Extension Warrants that would become issuable to the Holder, or the interest that would begin to accrue at 12% per annum under the Holder Note if the Holder Note is not repaid on or before the Extended Maturity Date; and
WHEREAS, the observance of any term of the Purchase Agreement may be waived with the written consent of the Company, the Holder and 21 April Fund, LP.
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
|
|
1. |
Waiver of Extension Warrants and Interest for Period from Initial Term through Extended Maturity Date |
The Holder hereby waives (a) the right to receive any Extension Warrants from the Company as a result of the Company’s election to extend the maturity date of the Holder Note beyond the Initial Term and (b) the right to receive interest that would otherwise accrue during the period from the end of the Initial Maturity Date through the Extended Maturity Date; provided, however, that the Holder does not waive the right to receive Extension Warrants or interest that would become issuable and payable, respectively, in the event that the Holder Note is not repaid in full on or prior to the Extended Maturity Date.
2.Confirmation. Except as expressly waived herein, all of the terms and provisions of the Purchase Agreement and, for the avoidance of doubt, the Holder Note, are unchanged and continue in full force and effect.
3.Counterparts. This Amendment may be executed in any number of counterparts, by facsimile if necessary, each of which shall be an original, but all of which together shall constitute one instrument.
4.Governing Law. This Amendment shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, excluding conflict of laws principles that would cause the application of laws of any other jurisdiction.
[remainder of page intentionally left blank]
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered as of the date first above written.
|
|
IDENTIV, INC. |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Sandra Wallach |
|
|
|
Name: |
Sandra Wallach |
|
|
|
Title: |
CFO |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21 APRIL FUND, LTD. |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Michael M. Kellen |
|
|
|
Name: |
Michael M. Kellen |
|
|
|
Title: |
Authorized Person / Portfolio Manager |
|
|
|
|
|
|
|
|
21 APRIL FUND, LP |
||
|
|
|
|
|
|
|
By: |
/s/ Michael M. Kellen |
|
|
|
Name: |
Michael M. Kellen |
|
|
|
Title: |
Authorized Person / Portfolio Manager |
|
IDENTIV, INC.
SIGNATURE PAGE TO
AMENDMENT TO NOTE
Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Steven Humphreys, certify that:
|
1. |
I have reviewed this Quarterly Report on Form 10-Q of Identiv, Inc.; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5. |
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
|
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
|
Date: May 10, 2021 |
|
/s/ Steven Humphreys |
|
|
|
Steven Humphreys |
|
|
|
Chief Executive Officer |
|
|
|
(Principal Executive Officer) |
Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Sandra Wallach, certify that:
|
1. |
I have reviewed this Quarterly Report on Form 10-Q of Identiv, Inc.; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5. |
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
|
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
|
Date: May 10, 2021 |
|
/s/ Sandra Wallach |
|
|
|
Sandra Wallach |
|
|
|
Chief Financial Officer and Secretary |
|
|
|
(Principal Financial and Accounting Officer) |
xhibit 32
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Steven Humphreys, the Chief Executive Officer of Identiv, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: (1) the Quarterly Report of Identiv, Inc. on Form 10-Q for the quarterly period ended March 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (2) the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Identiv, Inc.
|
Date: May 10, 2021 |
|
/s/ Steven Humphreys |
|
|
|
Steven Humphreys |
|
|
|
Chief Executive Officer |
|
|
|
(Principal Executive Officer) |
I, Sandra Wallach, the Chief Financial Officer of Identiv, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: (1) the Quarterly Report of Identiv, Inc. on Form 10-Q for the quarterly period ended March 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (2) the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Identiv, Inc.
|
Date: May 10, 2021 |
|
/s/ Sandra Wallach |
|
|
|
Sandra Wallach |
|
|
|
Chief Financial Officer and Secretary |
|
|
|
(Principal Financial and Accounting Officer) |